<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32116539</article-id>
<article-id pub-id-type="pmc">7018710</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2019.00329</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Zebrafish as a Model System for the Study of Severe Ca<sub>V</sub>2.1 (α<sub>1A</sub>) Channelopathies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tyagi</surname>
<given-names>Sidharth</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/827819/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ribera</surname>
<given-names>Angeles B.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/710787/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bannister</surname>
<given-names>Roger A.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/39189/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Medical Scientist Training Program, Yale University School of Medicine</institution>, <addr-line>New Haven, CT</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Physiology and Biophysics, University of Colorado School of Medicine</institution>, <addr-line>Aurora, CO</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Pathology, University of Maryland School of Medicine</institution>, <addr-line>Baltimore, MD</addr-line>, <country>United States</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine</institution>, <addr-line>Baltimore, MD</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Baojin Ding, University of Louisiana at Lafayette, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Paul Brehm, Oregon Health &amp; Science University, United States; Jose M. Fernandez-Fernandez, Pompeu Fabra University, Spain; Noèlia Fernàndez-Castillo, Center for Biomedical Research in the Network of Rare Diseases (CIBERER), Spain</p>
</fn>
<corresp id="c001">*Correspondence: Roger A. Bannister <email>rbannister@som.umaryland.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>12</volume>
<elocation-id>329</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>10</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>12</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Tyagi, Ribera and Bannister.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Tyagi, Ribera and Bannister</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The P/Q-type Ca<sub>V</sub>2.1 channel regulates neurotransmitter release at neuromuscular junctions (NMJ) and many central synapses. <italic>CACNA1A</italic> encodes the pore-containing α<sub>1A</sub> subunit of Ca<sub>V</sub>2.1 channels. In humans, <italic>de novo CACNA1A</italic> mutations result in a wide spectrum of neurological, neuromuscular, and movement disorders, such as familial hemiplegic migraine type 1 (FHM1), episodic ataxia type 2 (EA2), as well as a more recently discovered class of more severe disorders, which are characterized by ataxia, hypotonia, cerebellar atrophy, and cognitive/developmental delay. Heterologous expression of Ca<sub>V</sub>2.1 channels has allowed for an understanding of the consequences of <italic>CACNA1A</italic> missense mutations on channel function. In contrast, a mechanistic understanding of how specific <italic>CACNA1A</italic> mutations lead <italic>in vivo</italic> to the resultant phenotypes is lacking. In this review, we present the zebrafish as a model to both study <italic>in vivo</italic> mechanisms of <italic>CACNA1A</italic> mutations that result in synaptic and behavioral defects and to screen for effective drug therapies to combat these and other Ca<sub>V</sub>2.1 channelopathies.</p>
</abstract>
<kwd-group>
<kwd>Ca<sub>V</sub>2.1</kwd>
<kwd>α<sub>1A</sub></kwd>
<kwd>P/Q-type</kwd>
<kwd>channelopathy</kwd>
<kwd>familial hemiplegic migraine type 1</kwd>
<kwd>episodic ataxia type 2</kwd>
<kwd>vertebrate models</kwd>
<kwd>zebrafish</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">National Institute of Neurological Disorders and Stroke<named-content content-type="fundref-id">10.13039/100000065</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn002">Boettcher Foundation<named-content content-type="fundref-id">10.13039/100005508</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="140"></ref-count>
<page-count count="12"></page-count>
<word-count count="9921"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>P/Q-type Ca<sub>V</sub>2.1 channels are the predominant voltage-gated Ca<sup>2+</sup> channel isoform present at the neuromuscular junction (NMJ) and most central synapses. Since Ca<sup>2+</sup> flux <italic>via</italic> these channels is critical for neurotransmitter release (Llinás et al., <xref ref-type="bibr" rid="B69">1981</xref>; Turner et al., <xref ref-type="bibr" rid="B117">1992</xref>; Uchitel et al., <xref ref-type="bibr" rid="B119">1992</xref>; Dunlap et al., <xref ref-type="bibr" rid="B31">1994</xref>, <xref ref-type="bibr" rid="B30">1995</xref>; Ludwig et al., <xref ref-type="bibr" rid="B71">1997</xref>), mutations in the Ca<sub>V</sub>2.1 α<sub>1A</sub> subunit would be expected to impact synaptic efficacy. However, as discussed in sections “Ca<sub>V</sub>2.1 Channel Composition” to “The Expanding Spectrum OF Ca<sub>V</sub>2.1-α<sub>1A</sub> Channelopathies” the direct consequences of mutations on channel function and the resultant neurologic phenotypes vary significantly. For example, two well-studied channelopathies—episodic ataxia type 2 (EA2) and familial hemiplegic migraine type 1 (FHM1)—arise from point mutations in the <italic>CACNA1A</italic> gene that encodes the α<sub>1A</sub> subunit (Jen et al., <xref ref-type="bibr" rid="B54">2007</xref>; Pietrobon, <xref ref-type="bibr" rid="B90">2007</xref>, <xref ref-type="bibr" rid="B91">2010</xref>). The mutations that lead to EA2 tend to be loss-of-function mutations, while gain-of-function mutations usually underlie FHM1 (Jen et al., <xref ref-type="bibr" rid="B53">2001</xref>; Tottene et al., <xref ref-type="bibr" rid="B114">2002</xref>; Kaja et al., <xref ref-type="bibr" rid="B62">2005</xref>, <xref ref-type="bibr" rid="B61">2010</xref>; Mantuano et al., <xref ref-type="bibr" rid="B75">2010</xref>; Rajakulendran et al., <xref ref-type="bibr" rid="B95">2010b</xref>; Di Guilmi et al., <xref ref-type="bibr" rid="B26">2014</xref>; Rose et al., <xref ref-type="bibr" rid="B98">2014</xref>; Brusich et al., <xref ref-type="bibr" rid="B11">2018</xref>). However, some ataxic cases have paradoxically been linked to gain-of-channel function mutations (e.g., van den Maagdenberg et al., <xref ref-type="bibr" rid="B123">2010</xref>; Knierim et al., <xref ref-type="bibr" rid="B64">2011</xref>; Gao et al., <xref ref-type="bibr" rid="B38">2012</xref>; Bahamonde et al., <xref ref-type="bibr" rid="B5">2015</xref>; Jiang et al., <xref ref-type="bibr" rid="B58">2019</xref>). These latter examples underscore the diversity of channel dysfunction in this expanding spectrum of ataxic disorders and highlight the need for a model system to rapidly and effectively identify pathological phenotypes.</p>
<p>In this article, we review the: (1) basic information about the Ca<sub>V</sub>2.1 channel heteromultimer; (2) two relatively well-characterized diseases caused by mutation of the Ca<sub>V</sub>2.1 α<sub>1A</sub> subunit—EA2 and FHM1; (3) the emerging full spectrum of Ca<sub>V</sub>2.1 α<sub>1A</sub> channelopathies; and (4) the potential that the zebrafish model holds for understanding disease mechanisms and discovering potential therapeutics. Sections “Introduction” to “Familial Hemiplegic Migraine Type 1” are intended to provide sufficient background for the more profound discussion of the more severe neurodevelopmental disorders, which are caused by point mutations in <italic>CACNA1A</italic> in section “The Expanding Spectrum OF Ca<sub>V</sub>2.1-α<sub>1A</sub> Channelopathies.” It is important to note that the pathology of this unnamed class of disorders resembles that of spinocerebellar ataxia type 6 (SCA), which is caused by the addition of excess CAG polynucleotide repeats to the <italic>CACNA1A</italic> transcript (Jodice et al., <xref ref-type="bibr" rid="B59">1997</xref>).</p>
</sec>
<sec id="s2">
<title>Ca<sub>V</sub>2.1 Channel Composition</title>
<p>High voltage-activated Ca<sup>2+</sup> channels, such as the Ca<sub>V</sub>2.1 heteromultimer, are composed minimally of a principal α<sub>1</sub> subunit (α<sub>1A</sub>) and auxiliary β and α<sub>2</sub>δ subunits (Volsen et al., <xref ref-type="bibr" rid="B125">1997</xref>; Catterall, <xref ref-type="bibr" rid="B18">2010</xref>; Dolphin, <xref ref-type="bibr" rid="B28">2016</xref>). For Ca<sub>V</sub>2.1, an interaction with a γ<sub>2</sub> subunit (a.k.a., stargazin) was also reported (Letts et al., <xref ref-type="bibr" rid="B68">1998</xref>; Kang and Campbell, <xref ref-type="bibr" rid="B63">2003</xref>). Like the other nine members of the Ca<sub>V</sub> family, α<sub>1A</sub> subunits have four transmembrane repeats (I–IV), each with six membrane-spanning α-helices (S1–S6; Mori et al., <xref ref-type="bibr" rid="B81">1991</xref>; please see <xref ref-type="fig" rid="F1">Figure 1</xref>). Of these, the S4 α-helices are thought to be the primary voltage-sensing elements of the channel, a function which is conferred by five to six positively charged amino acids lining a face of the α-helix (Aggarwal and MacKinnon, <xref ref-type="bibr" rid="B2">1996</xref>). The S1–S3 helices form an aqueous conduit that enables passage of the S4 α-helix through the membrane field by facilitating interactions with residues of the “charge transfer center” (formed by conserved negative, polar and hydrophobic residues on the S2 segment and an invariant aspartate residue on the S3 helix; Tao et al., <xref ref-type="bibr" rid="B110">2010</xref>); the S5 and S6 helices line the conventional channel conduction pore (Neely and Hidalgo, <xref ref-type="bibr" rid="B82">2014</xref>; Hering et al., <xref ref-type="bibr" rid="B48">2018</xref>). The relatively long extracellular segment linking the S5 and S6 helices (a.k.a., the P-loop) contains a highly conserved glutamate residue in all four repeats. These four glutamates form the selectivity filter (Yang et al., <xref ref-type="bibr" rid="B135">1993</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Schematic representation of human Ca<sub>V</sub>2.1 mutations causing episodic ataxia type 2 (EA2). Please note that residue numbering varies between studies due to the existence of multiple <italic>CACNA1A</italic> splice variants; residue numbers indicated reflect those stated in the original report. Citations to the indicated mutations are listed as follows: E147K—Imbrici et al., <xref ref-type="bibr" rid="B49">2004</xref>; G162V—Maksemous et al. (<xref ref-type="bibr" rid="B74">2016</xref>); R192W—Soden et al. (<xref ref-type="bibr" rid="B106">2014</xref>); R198Q—Indelicato et al. (<xref ref-type="bibr" rid="B50">2019</xref>); Y248C—Zafeiriou et al. (<xref ref-type="bibr" rid="B139">2009</xref>); Y248N—Choi et al. (<xref ref-type="bibr" rid="B19">2017</xref>); H253Y—van den Maagdenberg et al. (<xref ref-type="bibr" rid="B121">2002</xref>); C256R—Mantuano et al. (<xref ref-type="bibr" rid="B76">2004</xref>); R279C—Maksemous et al. (<xref ref-type="bibr" rid="B74">2016</xref>); C287Y—Jen et al. (<xref ref-type="bibr" rid="B52">2004</xref>); G293R—Yue et al. (<xref ref-type="bibr" rid="B138">1997</xref>); G297R—Tantsis et al. (<xref ref-type="bibr" rid="B109">2016</xref>); D302N—Maksemous et al. (<xref ref-type="bibr" rid="B74">2016</xref>); R387G—Maksemous et al. (<xref ref-type="bibr" rid="B74">2016</xref>); E388K—Nikaido et al. (<xref ref-type="bibr" rid="B83">2011</xref>); L389F—Mantuano et al. (<xref ref-type="bibr" rid="B75">2010</xref>); G411W—Maksemous et al. (<xref ref-type="bibr" rid="B74">2016</xref>); A454T—Cricchi et al. (<xref ref-type="bibr" rid="B20">2007</xref>); R455Q—Isaacs et al. (<xref ref-type="bibr" rid="B51">2017</xref>); T501M—Mantuano et al. (<xref ref-type="bibr" rid="B75">2010</xref>); G533K—Scoggan et al. (<xref ref-type="bibr" rid="B99">2006</xref>); G540R—Rajakulendran et al. (<xref ref-type="bibr" rid="B93">2010a</xref>); L621R—Rajakulendran et al. (<xref ref-type="bibr" rid="B93">2010a</xref>); G638D—Cuenca-León et al. (<xref ref-type="bibr" rid="B21">2009</xref>); I712V—Guerin et al. (<xref ref-type="bibr" rid="B45">2008</xref>); M798T—Mantuano et al. (<xref ref-type="bibr" rid="B75">2010</xref>); P897R—Mantuano et al. (<xref ref-type="bibr" rid="B75">2010</xref>); F1404C—Jen et al. (<xref ref-type="bibr" rid="B53">2001</xref>); R1433Q—Pietrobon (<xref ref-type="bibr" rid="B91">2010</xref>); G1483R—Mantuano et al. (<xref ref-type="bibr" rid="B76">2004</xref>); F1491S—Guida et al. (<xref ref-type="bibr" rid="B46">2001</xref>); V1494I—Mantuano et al. (<xref ref-type="bibr" rid="B76">2004</xref>); R1662H—Friend et al. (<xref ref-type="bibr" rid="B36">1999</xref>); R1665Q—Tonelli et al. (<xref ref-type="bibr" rid="B113">2006</xref>); R1680C—Mantuano et al. (<xref ref-type="bibr" rid="B75">2010</xref>); H1737L—Spacey et al. (<xref ref-type="bibr" rid="B107">2004</xref>); L1749P—Maksemous et al. (<xref ref-type="bibr" rid="B74">2016</xref>); R1751W—Bertholon et al. (<xref ref-type="bibr" rid="B8">2009</xref>); E1757K—Denier et al. (<xref ref-type="bibr" rid="B25">2001</xref>); S1799L—Ohba et al. (<xref ref-type="bibr" rid="B84">2013</xref>); C1870R—Mantuano et al. (<xref ref-type="bibr" rid="B75">2010</xref>); R2090Q—Melzer et al. (<xref ref-type="bibr" rid="B78">2010</xref>); R2136C—Mantuano et al. (<xref ref-type="bibr" rid="B76">2004</xref>); P2222L—Sintas et al. (<xref ref-type="bibr" rid="B104">2017</xref>). The Ca<sub>V</sub>2.1 schematic was modified from Tyagi et al. (<xref ref-type="bibr" rid="B118">2019</xref>) with permission of the authors.</p>
</caption>
<graphic xlink:href="fnmol-12-00329-g0001"></graphic>
</fig>
</sec>
<sec id="s3">
<title>Episodic Ataxia Type 2</title>
<p>EA2 is a rare neurological disease characterized by paroxysmal attacks of ataxia, nystagmus, and vertigo. The majority of <italic>CACNA1A</italic> mutations that lead to EA2 result in Ca<sub>V</sub>2.1 loss of function by premature termination of the open reading frame, resulting in rapid degradation of truncated protein products (Jen et al., <xref ref-type="bibr" rid="B53">2001</xref>; Pietrobon, <xref ref-type="bibr" rid="B91">2010</xref>; Sintas et al., <xref ref-type="bibr" rid="B104">2017</xref>). Indeed, over 40 pathogenic missense mutations were identified (Pietrobon, <xref ref-type="bibr" rid="B91">2010</xref>; Sintas et al., <xref ref-type="bibr" rid="B104">2017</xref>; see <xref ref-type="fig" rid="F1">Figure 1</xref>). Most of these amino acid substitutions reside in the P-loop or the S5 and S6 helices, themselves, suggesting that impaired ability to form a fully functional channel pore is the likely pathophysiological mechanism of the resultant phenotype for the majority of EA2 missense cases (Jen et al., <xref ref-type="bibr" rid="B54">2007</xref>; Sintas et al., <xref ref-type="bibr" rid="B104">2017</xref>). In some cases, a complete loss of function was observed with missense mutants, likely attributable to ER-associated degradation of the mutant channel and subsequent lack of trafficking to the surface membrane (Page et al., <xref ref-type="bibr" rid="B86">2004</xref>). In addition, some EA2 mutants (e.g., E1761K, F1406C) seem to exert a dominant-negative effect since coexpression of mutant channels with wild-type channels in <italic>Xenopus</italic> oocytes diminished the amplitude of Ca<sup>2+</sup> current elicited by depolarization (Jeng et al., <xref ref-type="bibr" rid="B55">2006</xref>, <xref ref-type="bibr" rid="B56">2008</xref>; Mezghrani et al., <xref ref-type="bibr" rid="B79">2008</xref>). In these latter cases, it was postulated that misfolded mutant channels bound wild-type channels and subsequently induced degradation (Page et al., <xref ref-type="bibr" rid="B87">2010</xref>; Rajakulendran et al., <xref ref-type="bibr" rid="B94">2012</xref>; Dahimene et al., <xref ref-type="bibr" rid="B23">2016</xref>) or competed successfully with the wild-type channel for a limited number of “slots” reserved for Ca<sub>V</sub>2.1 channels at the plasma membrane (Cao et al., <xref ref-type="bibr" rid="B15">2004</xref>; Cao and Tsien, <xref ref-type="bibr" rid="B14">2010</xref>; but see below). In addition, some mutations (e.g., H1736L, A1293D/delY1294, G293R) do not completely abolish channel activity but rather shift the voltage-dependence of Ca<sub>V</sub>2.1 activation to somewhat more positive potentials, thereby decreasing channel open probability (P<sub>o</sub>; Wappl et al., <xref ref-type="bibr" rid="B126">2002</xref>; Spacey et al., <xref ref-type="bibr" rid="B107">2004</xref>; Pietrobon, <xref ref-type="bibr" rid="B91">2010</xref>).</p>
<p>In a minority of cases, EA2 is precipitated by gain-of-channel function mutations, which suggests that a critical bandwith of Ca<sup>2+</sup> flux is required to avoid pathogenicity (e.g., Mantuano et al., <xref ref-type="bibr" rid="B75">2010</xref>; Knierim et al., <xref ref-type="bibr" rid="B64">2011</xref>; Gao et al., <xref ref-type="bibr" rid="B38">2012</xref>; Carreño et al., <xref ref-type="bibr" rid="B16">2013</xref>; Bahamonde et al., <xref ref-type="bibr" rid="B5">2015</xref>). For many yet-to-be characterized Cav2.1 EA2 mutations, whether the mutation produces gain- or loss-of-channel function remains to be seen. Still, these findings underscore the need to resist generalization regarding pathological mechanisms without rigorous investigation of each mutation.</p>
</sec>
<sec id="s4">
<title>Familial Hemiplegic Migraine Type 1</title>
<p>FHM1 is an inherited migraine condition that results in weakness of half the body for prolonged periods of time. Patients afflicted with FHM1 often display cerebellar degeneration (Elliot et al., <xref ref-type="bibr" rid="B32">1996</xref>). As noted above, FHM1 is most often linked to gain-of-function point mutations in <italic>CACNA1A</italic> (Tottene et al., <xref ref-type="bibr" rid="B114">2002</xref>; Pietrobon, <xref ref-type="bibr" rid="B90">2007</xref>; see <xref ref-type="fig" rid="F2">Figure 2</xref>). These substitutions occur at a variety of loci within the channel but most commonly in residues thought to line the pore, the S3–S4 or S5–S6 linkers, or the S4 voltage sensor. Even though the locations of the mutations within the channel are variable, analysis in heterologous systems revealed a hyperpolarizing shift in channel activation for most studied mutants (Hans et al., <xref ref-type="bibr" rid="B47">1999</xref>; Tottene et al., <xref ref-type="bibr" rid="B114">2002</xref>, <xref ref-type="bibr" rid="B115">2005</xref>; Adams et al., <xref ref-type="bibr" rid="B1">2009</xref>; Serra et al., <xref ref-type="bibr" rid="B100">2009</xref>). Since these channels open at more hyperpolarizing potentials, channel <italic>P</italic><sub>o</sub> is enhanced, and an FHM1 mutant Ca<sub>V</sub>2.1 channel can carry greater Ca<sup>2+</sup> influx than its wild-type counterpart at physiologically relevant membrane potentials. This process may be further facilitated by a reduction in the direct Gβγ-mediated inhibition of presynaptic FHM1 mutant Ca<sub>V</sub>2.1 channels (Melliti et al., <xref ref-type="bibr" rid="B77">2003</xref>; Weiss et al., <xref ref-type="bibr" rid="B127">2008</xref>; Serra et al., <xref ref-type="bibr" rid="B100">2009</xref>; Garza-López et al., <xref ref-type="bibr" rid="B41">2012</xref>, <xref ref-type="bibr" rid="B40">2013</xref>). Mouse knock-in models carrying FHM1-causing Ca<sub>V</sub>2.1 mutations display the migraine aura, cortical spreading depression characteristic of human FHM1 (van den Maagdenberg et al., <xref ref-type="bibr" rid="B122">2004</xref>, <xref ref-type="bibr" rid="B123">2010</xref>). While these gain-of-function biophysical effects of FHM1 mutations are fairly consistent, it is important to state that FHM1 pathology is inarguably a reflection of the balance of the relative manifestation of the mutations between excitatory and inhibitory circuits (Vecchia et al., <xref ref-type="bibr" rid="B124">2015</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Schematic representation of human Ca<sub>V</sub>2.1 mutations causing familial hemiplegic migraine type 1 (FHM1). Please note that residue numbering varies between studies due to the existence of multiple <italic>CACNA1A</italic> splice variants; residue numbers indicated reflect those stated in the original report. Citations to the indicated mutations are listed as follows: R192Q—Ophoff et al. (<xref ref-type="bibr" rid="B85">1996</xref>); R195K—Ducros et al. (<xref ref-type="bibr" rid="B29">2001</xref>); S218L—Kors et al. (<xref ref-type="bibr" rid="B66">2001</xref>); P225H—Stuart et al. (<xref ref-type="bibr" rid="B108">2012</xref>); G230V—Yang et al. (<xref ref-type="bibr" rid="B136">2014</xref>); F363S—Riant et al. (<xref ref-type="bibr" rid="B96">2010</xref>); V581M—Cuenca-León et al. (<xref ref-type="bibr" rid="B22">2008</xref>); V581L—Freilinger et al. (<xref ref-type="bibr" rid="B35">2011</xref>); R583Q—Battistini et al. (<xref ref-type="bibr" rid="B6">1999</xref>); T666M—Ophoff et al. (<xref ref-type="bibr" rid="B85">1996</xref>); V714A—Ophoff et al. (<xref ref-type="bibr" rid="B85">1996</xref>); D715E—Ducros et al. (<xref ref-type="bibr" rid="B29">2001</xref>); E1015K—Grieco et al. (<xref ref-type="bibr" rid="B43">2018</xref>); Y1245C—Cuenca-León et al. (<xref ref-type="bibr" rid="B22">2008</xref>); K1336E—Ducros et al. (<xref ref-type="bibr" rid="B29">2001</xref>); R1347Q—Alonso et al. (<xref ref-type="bibr" rid="B3">2004</xref>); C1370Y—Thomsen et al. (<xref ref-type="bibr" rid="B112">2007</xref>); Y1385C—Vahedi et al. (<xref ref-type="bibr" rid="B120">2000</xref>); V1457L—Carrera et al. (<xref ref-type="bibr" rid="B17">1999</xref>); F1506S—Riant et al. (<xref ref-type="bibr" rid="B96">2010</xref>); F1506Y—Pelzer et al. (<xref ref-type="bibr" rid="B88">2018</xref>); I1512T—Grieco et al. (<xref ref-type="bibr" rid="B43">2018</xref>); C1535S—Dichgans et al. (<xref ref-type="bibr" rid="B27">2005</xref>); F1609L—Pelzer et al. (<xref ref-type="bibr" rid="B88">2018</xref>); R1668W—Ducros et al. (<xref ref-type="bibr" rid="B29">2001</xref>); K1670R—Riant et al. (<xref ref-type="bibr" rid="B96">2010</xref>); L1682P—Weiss et al. (<xref ref-type="bibr" rid="B128">2007</xref>); W1684R—Ducros et al. (<xref ref-type="bibr" rid="B29">2001</xref>); V1696I—Ducros et al. (<xref ref-type="bibr" rid="B29">2001</xref>); I1710T—Kors et al. (<xref ref-type="bibr" rid="B65">2004</xref>); D1725N—Riant et al. (<xref ref-type="bibr" rid="B96">2010</xref>); I1811L—Ophoff et al. (<xref ref-type="bibr" rid="B85">1996</xref>); A2006T—Wilson (<xref ref-type="bibr" rid="B131">2014</xref>); R2157G—Grieco et al. (<xref ref-type="bibr" rid="B43">2018</xref>). The Ca<sub>V</sub>2.1 schematic was modified from Tyagi et al. (<xref ref-type="bibr" rid="B118">2019</xref>) with permission of the authors.</p>
</caption>
<graphic xlink:href="fnmol-12-00329-g0002"></graphic>
</fig>
</sec>
<sec id="s5">
<title>The Expanding Spectrum of Ca<sub>V</sub>2.1-α<sub>1A</sub> Channelopathies</title>
<p>EA2 and FHM1 have long been known to be caused primarily by point mutations in Ca<sub>V</sub>2.1 in addition to a few variants that carry deletions or insertions (Jen et al., <xref ref-type="bibr" rid="B53">2001</xref>; Pietrobon, <xref ref-type="bibr" rid="B90">2007</xref>, <xref ref-type="bibr" rid="B91">2010</xref>). However, the biophysical effects of these mutations on channel function are often subtle, and the manifestations of ataxia are paroxysmal (Elliot et al., <xref ref-type="bibr" rid="B32">1996</xref>; Jen et al., <xref ref-type="bibr" rid="B54">2007</xref>; Sintas et al., <xref ref-type="bibr" rid="B104">2017</xref>). With the innovative whole-exome sequencing approach, a new, but yet-to-be-named, class of Ca<sub>V</sub>2.1-linked disorders with developmental components was identified and linked to point mutations in Ca<sub>V</sub>2.1 (Tonelli et al., <xref ref-type="bibr" rid="B113">2006</xref>; Blumkin et al., <xref ref-type="bibr" rid="B9">2010</xref>; Romaniello et al., <xref ref-type="bibr" rid="B97">2010</xref>; Epi4K Consortium and Epilepsy Phenome/Genome Project, <xref ref-type="bibr" rid="B33">2013</xref>; Damaj et al., <xref ref-type="bibr" rid="B24">2015</xref>; Jiang et al., <xref ref-type="bibr" rid="B57">2016</xref>; Weyhrauch et al., <xref ref-type="bibr" rid="B130">2016</xref>; Luo et al., <xref ref-type="bibr" rid="B72">2017</xref>; Travaglini et al., <xref ref-type="bibr" rid="B116">2017</xref>). These disorders represent the far end of the Ca<sub>V</sub>2.1 channelopathy spectrum, which includes FHM1 and EA2. As is the case with spectrum disorders, these more severe disorders often share the characteristics of migraine and ataxia with FHM1 and EA2, respectively. However, the more severe disorders display cognitive deficits, epilepsies, and neurodegeneration that are infrequently observed with FHM1 and EA2 patients. Though similar in presentation, disorders resulting from Ca<sub>V</sub>2.1 missense mutations differ in etiology from SCA6, which is caused by increasing polyglutamine expansions on the channel carboxyl-terminus (Jodice et al., <xref ref-type="bibr" rid="B59">1997</xref>; Frontali, <xref ref-type="bibr" rid="B37">2001</xref>). Moreover, the scattering of mutations within the channel suggests that there are a variety of mechanisms for channel dysfunction underlying this class of disorders (<xref ref-type="fig" rid="F3">Figure 3</xref>). For example, Romaniello et al. (<xref ref-type="bibr" rid="B97">2010</xref>) described an A405T substitution in a 12-year-old girl with a family history of Ca<sub>V</sub>2.1 mutation-linked disorders. The patient presented with persistent cerebellar signs (i.e., ataxia, dysmetria, hypotonia) and developmental delay. A405T represents a non-polar to polar substitution in the Repeat I–II linker region of Ca<sub>V</sub>2.1 (<xref ref-type="fig" rid="F1">Figure 1</xref>). The Repeat I–II linker is putatively the site where the auxiliary β subunit interacts with the α<sub>1A</sub> subunit (Campiglio and Flucher, <xref ref-type="bibr" rid="B13">2015</xref>). A reasonable, but yet-to-be-tested, hypothesis is that the A405T substitution disrupts the α<sub>1A</sub>-β subunit interaction in much the same way as does an engineered Y392S swap in the I–II loop (Pragnell et al., <xref ref-type="bibr" rid="B92">1994</xref>). Such a disruption would substantially decrease surface expression of the channel by impeding trafficking and, given reduced production of the wild-type protein, would likely result in haploinsufficiency. An alternate explanation is that the A405T substitution that impacts neurotransmitter release, similar to another ataxic variant in the I–II linker, A454T, was demonstrated to curb modulation of Ca<sub>V</sub>2.1 by SNARE proteins <italic>via</italic> a mechanism involving the β subunit (Cricchi et al., <xref ref-type="bibr" rid="B20">2007</xref>; Serra et al., <xref ref-type="bibr" rid="B101">2010</xref>, <xref ref-type="bibr" rid="B102">2018</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Missense Ca<sub>V</sub>2.1 mutations leading to neurodevelopmental disorders. The zebrafish <italic>fakir</italic> and <italic>tb204a</italic> mutants are also depicted as yellow circles. Red circles indicate a loss-of-function human mutation. Blue circles indicate a gain-of-function human mutation. Magenta circles indicate a yet-to-be functionally characterized human mutation. Specific references are indicated below. As in <xref ref-type="fig" rid="F1">Figures 1</xref>, <xref ref-type="fig" rid="F2">2</xref>, please note that residue numbering varies between studies due to: (1) the existence of multiple known <italic>CACNA1A</italic> splice variants; and (2) species differences between humans and zebrafish. The Ca<sub>V</sub>2.1 schematic was modified from Tyagi et al. (<xref ref-type="bibr" rid="B118">2019</xref>) with permission of the authors. These mutations are discussed in sections “The Expanding Spectrum OF Ca<sub>V</sub>2.1-α<sub>1A</sub> Channelopathies” and “Zebrafish as a Model SYSTEM for the Study of Severe Ca<sub>V</sub>2.1 Channelopathies.”</p>
</caption>
<graphic xlink:href="fnmol-12-00329-g0003"></graphic>
</fig>
<p>Blumkin et al. (<xref ref-type="bibr" rid="B9">2010</xref>) reported a R1350Q substitution in a 7-year-old male patient that also presented with cerebellar ataxia, developmental delay, and nonspecific dyskinesia. Although the outward presentation was similar to the patient carrying the A405T substitution, the R1350Q swap inserted a neutral glutamine in place of a basic arginine in the S4 voltage-sensing α-helix of Repeat III (<xref ref-type="fig" rid="F1">Figure 1</xref>). An arginine to glutamine substitution at this position was also reported with a patient exhibiting tremor that was alleviated by a Ca<sup>2+</sup> channel blocker (R1345Q in Jiang et al., <xref ref-type="bibr" rid="B57">2016</xref>). Based on the observation that the equivalent substitution in the <italic>tottering</italic> mutant mouse causes a ~12-mV hyperpolarizing shift in activation (Miki et al., <xref ref-type="bibr" rid="B80">2008</xref>), it is likely that neutralization of this basic residue may have facilitated the movement of the voltage sensor through the membrane field. Such gain of function contrasts with the findings of Weyhrauch et al. (<xref ref-type="bibr" rid="B130">2016</xref>), who also described a mutation in the S4 voltage sensor of Repeat III (P1353L) found in a child with developmental delay, gross motor delay, and congenital hypotonia (<xref ref-type="fig" rid="F1">Figure 1</xref>). Electrophysiological analysis of mutant channels expressed heterologously in HEK293 cells revealed near 100% ablation of Ca<sub>V</sub>2.1-mediated Ca<sup>2+</sup> current, suggesting that either dominant-negative effects or haploinsufficiency underlies the phenotype. The first possibility was proposed on the basis that mice with only one <italic>CACNA1A</italic> allele seems normal (Jun et al., <xref ref-type="bibr" rid="B60">1999</xref>). However, the ability of Ca<sub>V</sub>2.1P1353L to out-compete endogenously wild-type channels was not investigated in a neuronal context.</p>
<p>Travaglini et al. (<xref ref-type="bibr" rid="B116">2017</xref>) reported a pair of mutations, I1342T and V1396M, in two patients with similar clinical phenotypes involving congenital ataxia, hypotonia, and intellectual disability. The I1342T mutation resides in the extracellular loop between the S3 and S4 helix of α<sub>1A</sub> in close proximity to the beginning of the Repeat III S4 helix (<xref ref-type="fig" rid="F1">Figure 1</xref>). A reasonable hypothesis for the dysfunction of the I1342T mutant channel is that this substitution alters the conformation of the S4 helix and affects its mobility, though speculation on its relationship to ataxia, hypotonia, and intellectual disability is unfounded without more biophysical information regarding mutant channel dysfunction. The V1396M mutation is found in the proximal S5 pore-forming domain of Repeat III of α<sub>1A</sub>, a region of the channel that is also predicted to interact with the α<sub>2</sub>δ subunit on the basis of Ca<sub>V</sub>1.1 cryo-EM structure (Wu et al., <xref ref-type="bibr" rid="B132">2016</xref>). The idea that V1396M facilitates channel expression through an α<sub>2</sub>δ-mediated mechanism (see Dolphin, <xref ref-type="bibr" rid="B28">2016</xref>, for a review) is particularly intriguing since the current density for the mouse equivalent of Cav2.1 V1396M expressed in HEK293 cells was shown to be nearly double that of wild-type Cav2.1 (Jiang et al., <xref ref-type="bibr" rid="B58">2019</xref>). Though less striking, the introduction of methionine also causes a hyperpolarization in the voltage dependence of activation suggesting the disruption of an inter-helical interaction that restricts voltage-sensor translocation. Three other Ca<sub>V</sub>2.1mutants, which were linked to Lennox–Gastaut epileptic encephalopathy were examined in the same study and were found to have polar effects (Jiang et al., <xref ref-type="bibr" rid="B58">2019</xref>). The A715T mutation at the base of RIIS6 displayed a ~10-mV hyperpolarizing shift in activation, smaller but reminiscent of the ~20-mV hyperpolarizing shift observed in Purkinje cells of Ca<sub>V</sub>2.1 S218L EA2 model mice (Gao et al., <xref ref-type="bibr" rid="B38">2012</xref>). On the other hand, G232V and I1357S, at the bases of RIS5 and RIIS4 helices, respectively, reduced channel plasma membrane expression in both HEK293 and in cortical neurons.</p>
<p>Seminal work from Richard Tsien’s laboratory in the early 1990s revealed that four highly conserved glutamate residues within the P-loop are the structural basis of Ca<sup>2+</sup> selectivity among all Ca<sub>V</sub> channels (Yang et al., <xref ref-type="bibr" rid="B135">1993</xref>). Two such mutations in α<sub>1A</sub> are known to occur at the same glutamate in Repeat IV. Mutation of this residue to glycine causes ataxia and cognitive deficits running through three generations of the Slovak family (E1755G in Petrovicova et al., <xref ref-type="bibr" rid="B89">2017</xref>), and as noted above, a reversal of charge <italic>via</italic> substitution of a lysine for the glutamate causes EA2 (E1761K in Denier et al., <xref ref-type="bibr" rid="B25">2001</xref>). The glutamate to lysine mutation ablates inward Ba<sup>2+</sup> flux <italic>via</italic> the channel in <italic>Xenopus</italic> oocytes (Jeng et al., <xref ref-type="bibr" rid="B55">2006</xref>). Since coexpression of the Ca<sub>V</sub>2.1 E1761K mutant with the wild-type channel reduced the amplitude of the current in an RNA dose-dependent manner, the authors postulated that the E1761K resulted in a dominant-negative effect. While this mechanism could certainly underlie this particular channelopathy, conversion of any one of the glutamates in the selectivity filter to lysine effectively transforms Ca<sub>V</sub> channels into non-specific monovalent ion channels that are subject to block by divalent ions (Yang et al., <xref ref-type="bibr" rid="B135">1993</xref>). In this regard, Jeng et al. (<xref ref-type="bibr" rid="B55">2006</xref>) used a concentration of Ba<sup>2+</sup> (40 mM) in their experiments showing the ablation of inward current <italic>via</italic> E1761K channels, which most likely would have blocked the mutant channel. At more physiological divalent ion concentrations (i.e., &lt;2 mM Ca<sup>2+</sup>), currents carried by Na<sup>+</sup> and K<sup>+</sup> might be visible and pathogenic. Indeed, aberrant Na<sup>+</sup> and K<sup>+</sup> flux <italic>via</italic> Ca<sub>V</sub>1.2 Repeat III glutamate to lysine mutant channels can prolong action potential duration in cardiac-like iPSCs (Ye et al., <xref ref-type="bibr" rid="B137">2019</xref>), while the equivalent mutation in Ca<sub>V</sub>1.1 is postulated to cause K<sup>+</sup> accumulation in the transverse tubules (Beqollari et al., <xref ref-type="bibr" rid="B7">2018</xref>) and to accelerate muscle fatigue in mice (Lee et al., <xref ref-type="bibr" rid="B67">2015</xref>). Thus, the possibility that the E1761K mutation augments neurotransmitter release by prolonging neuronal action potential duration is not unreasonable, nor is the idea that excessive K<sup>+</sup> secretion into restricted extracellular compartments may excite neighboring neurons or vascular smooth muscle cells (see Filosa et al., <xref ref-type="bibr" rid="B34">2006</xref>).</p>
<p>Recently, Luo et al. (<xref ref-type="bibr" rid="B72">2017</xref>) described an 8-year-old female patient with congenital ataxia, hypotonia, cerebellar atrophy, and global developmental delay. The trio-based exome sequencing of this patient revealed a <italic>de novo</italic> missense mutation (R1673P) in the gene for Ca<sub>V</sub>2.1. The mutation resulted in an arginine to proline substitution within the Repeat IV S4 voltage-sensing helix of Ca<sub>V</sub>2.1. The R1673P mutation was predicted to be “probably damaging” by PolyPhen-2, a protein structure prediction software. As a means to identify the molecular mechanism by which R1673P precipitates the clinical phenotype, transgenic flies expressing the <italic>Drosophila</italic> equivalent of wild-type Ca<sub>V</sub>2.1 and Ca<sub>V</sub>2.1 R1673P in a Ca<sub>V</sub>2.1-deficient <italic>Drosophila</italic> (i.e., <italic>cacophony</italic> mutants) background were generated. In these experiments, the mutant Ca<sub>V</sub>2.1 R1673P was able to rescue the photoreceptor response in 3-day-old larvae to a greater extent than the wild-type channel suggesting a gain-of-function effect. At 30 days, the rescue of the electroretinogram had dissipated, but substantial photoreceptor degeneration was observed in the R1673P line but not in wild-type or Ca<sub>V</sub>2.1-deficient flies. It is possible that the early effects of gain-of-function Ca<sup>2+</sup>channel activity triggered neurodegeneration secondary to Ca<sup>2+</sup> toxicity. In contrast, however, voltage-clamp experiments showed that the R1673P mutation causes a profound loss-of-function for channels expressed heterologously in tsA-201 cells (Tyagi et al., <xref ref-type="bibr" rid="B118">2019</xref>). Specifically, the rat ortholog of R1673P (R1624P) displayed a ~25-mV depolarizing shift in activation and resultant weak activation at physiologically relevant membrane potentials. Further work is needed to understand how the loss of function at the molecular level leads to neurodegeneration at the systemic level.</p>
</sec>
<sec id="s6">
<title>Zebrafish as a Model System for the Study of Severe Ca<sub>V</sub>2.1 Channelopathies</title>
<p>Heterologous expression systems are the industry standard for the identification of pathogenic channel dysfunction. However, it is often difficult to extrapolate information gleaned using this approach to neurological dysfunction in patients. To bridge this gap, animal models are employed. Mice carrying FHM1 or EA2 mutations were very useful in understanding the pathophysiology underlying these disorders. However, no mouse line yet exists that models the more severe developmental disorders discussed above. The paucity of such models may be due to the uncertain viability or breeding capability of mice with grave developmental defects and the monetary risk associated with this endeavor. By contrast, simpler organisms like <italic>Drosophila</italic> have rapid propagation, are relatively easy to manipulate genetically, and lack the burden of cost. The obvious shortcoming of <italic>Drosophila</italic> is that insects are both phylogenetically and physiologically far removed from humans. A notable shortcoming is that <italic>Drosophila</italic> lack a true Ca<sub>V</sub>2.1 channel (Smith et al., <xref ref-type="bibr" rid="B105">1996</xref>).</p>
<p>Zebrafish—<italic>Danio rerio</italic>—offers a unique complement to the strengths of flies and mice as models for the study of severe Ca<sub>V</sub>2.1 channelopathies. The zebrafish is useful to investigate mechanisms because of the conservation of most fundamental physiology processes (e.g., neurotransmitter release) with mammals with a reduced risk of embryonic lethality. Similar to many zebrafish genes, the gene encoding the Ca<sub>V</sub>2.1 α-subunit is duplicated, yielding <italic>cacna1aa</italic> and <italic>cacna1ab</italic>. Two zebrafish loss-of-function <italic>cacna1ab</italic> mutants, <italic>tb204a</italic> (Wen et al., <xref ref-type="bibr" rid="B129">2013</xref>) and <italic>fakir</italic> (Low et al., <xref ref-type="bibr" rid="B70">2012</xref>), were studied previously. For both mutations, the loss-of-channel function was sizable, but incomplete. The <italic>tb204a</italic> mutation results in a tyrosine-to-asparagine substitution (Y1662N) within the carboxyl terminus of Ca<sub>V</sub>2.1a and a depolarizing shift in channel activation, similar to what was found for the rat cognate of Ca<sub>V</sub>2.1 R1673P (Tyagi et al., <xref ref-type="bibr" rid="B118">2019</xref>). Homozygous <italic>cacna1ab<sup>tb204a−/−</sup></italic> larvae were viable and had reduced motility. Moreover, there was an increased incidence of synaptic failure at the NMJ due to reduced Ca<sup>2+</sup> flux into the presynaptic NMJ, as detected by imaging of presynaptic intracellular Ca<sup>2+</sup> (Wen et al., <xref ref-type="bibr" rid="B129">2013</xref>). While this defect accurately predicted reduced motor function, neither sensory nor central effects of the mutation were assessed so their potential contribution to the behavioral phenotype cannot be excluded. Interestingly, both swimming behavior and NMJ synaptic transmission were rescued in <italic>cacna1ab<sup>tb204a−/−</sup></italic> larvae by 3,4-diaminopyridine (a K<sup>+</sup> channel blocker) and Roscovitine (a P/Q-type channel agonist; Yan et al., <xref ref-type="bibr" rid="B134">2002</xref>; Buraei et al., <xref ref-type="bibr" rid="B12">2007</xref>; Tarr et al., <xref ref-type="bibr" rid="B111">2013</xref>).</p>
<p>The <italic>fakir cacna1ab</italic> mutation results in a L356V substitution in the S6 helix of Repeat I (<xref ref-type="fig" rid="F1">Figure 1</xref>). Like the <italic>tb204a</italic> larvae, <italic>fakir</italic> mutants display reduced locomotor behavior compared to wild-type siblings. In addition, heterologously expressed <italic>fakir</italic> and <italic>tb204</italic> mutant channels had reductions in current amplitude and similar depolarizing shifts in channel activation properties (Low et al., <xref ref-type="bibr" rid="B70">2012</xref>; Wen et al., <xref ref-type="bibr" rid="B129">2013</xref>). <italic>a priori</italic>, L356V would appear to be a conservative amino acid change. However, L356 (located at the cytoplasmic side of S6 in RI) is highly conserved across species. Interestingly, the <italic>tb204a</italic> mutation (Y1662N) resides in an analogous location in S6 of RIV. While no disease-causing mutations have yet been identified in RIS6, human pathogenic point mutations were detected in the S6 helices of Repeats II–IV (<xref ref-type="fig" rid="F1">Figures 1</xref>–<xref ref-type="fig" rid="F3">3</xref>). Two of the mutations in S6 domains, V1494I and I1811L, would, similar to <italic>fakir</italic>, also be considered to be conservative substitutions. Overall, despite the identification of several S6 mutations, how L356V or other S6 mutations lead to perturbed channel function remains unknown. However, the fact that this is a highly conserved region across species suggests that mutations, even conservative ones, would be of consequence.</p>
<p>Despite the somewhat similar effects on channel activity produced by the two different <italic>cacna1ab</italic> mutations, substantially different mechanisms were proposed for how channel dysfunction leads to abnormal locomotor behavior. Consistent with the behavioral immotility, Low et al. (<xref ref-type="bibr" rid="B70">2012</xref>) found that rigorous swimming could be evoked in wild-type, but not <italic>fakir</italic> mutant, slow-twitch muscle by tactile stimulation. However, examination of responses to direct application of acetylcholine as well as miniature end plate current properties revealed little differences in transmission between motor neurons and slow-twitch fibers in <italic>fakir</italic> vs. wild-type larvae, nor were defects detected in evoked transmission between CaP motor neuron and fast-twitch muscle fibers. On this basis and consistent with the initial identification of <italic>fakir</italic> as a reduced touch-sensitive mutant (Granato et al., <xref ref-type="bibr" rid="B42">1996</xref>), Low et al. (<xref ref-type="bibr" rid="B70">2012</xref>) proposed that <italic>fakir</italic> mutants have defective swimming responses to tactile stimulation because the relevant sensory neuron Rohon–Beard cell required <italic>cacna1ab</italic> for function. However, this hypothesis was not tested directly by recording from Rohon–Beard neurons or their post-synaptic partners. In contrast, a study of the <italic>tb204</italic> allele provided strong evidence to support defective transmission at the NMJ (Wen et al., <xref ref-type="bibr" rid="B129">2013</xref>). Supporting evidence was provided by paired recordings between one type of motor neuron, CaP, and its fast-muscle target cell. Whether similar transmission defects occur at the NMJs formed between other motor neurons and muscle targets has not been studied. Thus, the mechanistic bases for the reduced motility defects of <italic>fakir</italic> and <italic>tb204a</italic> mutants have not been resolved.</p>
<p>Despite this impasse, the viability of both the <italic>fakir</italic> and the <italic>tb204</italic> mutant lines bodes well for the potential usefulness of zebrafish larvae carrying missense mutations corresponding to those which cause severe human Ca<sub>V</sub>2.1 channelopathies (e.g., Ca<sub>V</sub>2.1 R1673P). The generation of such models through CRISPR-Cas9 technology would enable the study of individual mutations with approaches encompassing the molecular, systemic, and behavioral levels. In particular, <italic>via</italic> paired CaP motor neuron—muscle recordings and imaging of depolarization-induced Ca<sup>2+</sup> flux into presynaptic terminals allow assessment of whether impairments in locomotor function result from NMJ defects.</p>
<p>Since zebrafish were successfully used to screen for compounds for the treatment of Dravet syndrome, a <italic>SCNA1A</italic>Na<sup>+</sup> channelopathy (Griffin et al., <xref ref-type="bibr" rid="B44">2017</xref>), one can envision that this approach could be used to identify and/or refine small molecules to combat both Ca<sub>V</sub>2.1 gain- and loss-of-function disorders. Compounds that partially counteract channel gain of function, notably gabapentin and pregabalin, were available for clinical use for sometime (Sills, <xref ref-type="bibr" rid="B103">2006</xref>). However, a need for alternatives arose as both the aforementioned compounds were shown to have some addictive capability (Bonnet et al., <xref ref-type="bibr" rid="B10">2018</xref>; Althobaiti et al., <xref ref-type="bibr" rid="B4">2019</xref>). In regard to loss-of-function disorders, 3,4-diaminopyridine was approved for acute treatment of Lambert—Eaton syndrome, a condition secondary to an aggressive lung cancer in which autoantibodies to Ca<sub>V</sub>2.1 are generated (García and Beam, <xref ref-type="bibr" rid="B39">1996</xref>; Maddison, <xref ref-type="bibr" rid="B73">2012</xref>). Unfortunately, the arrhythmogenic potential of this compound precludes its long-term use in other contexts including the neurodevelopmental disorders discussed above. By contrast, derivatives of Roscovitine, such as those pioneered by the Meriney group, are logical candidates for further development (Tarr et al., <xref ref-type="bibr" rid="B111">2013</xref>; Wu et al., <xref ref-type="bibr" rid="B133">2018</xref>). Another possibility, which may not be a stretch given nascent cryo-EM images and the increasingly frequent implementation of deep learning approaches, is the modification of the L-type channel agonist (-)Bay K 8644 for use as a specific P/Q-type channel agonist (Zhao et al., <xref ref-type="bibr" rid="B140">2019</xref>).</p>
<p>Despite these advantages, the zebrafish model system does pose some challenges. The fact that gene duplication endowed teleosts with two<italic> cacna1a</italic> genes can be problematic, even though the characterization of the <italic>tb204a</italic> mutant revealed that <italic>cacna1aa</italic> channel isoform makes little, if any, contribution to neurotransmission at the NMJ (Wen et al., <xref ref-type="bibr" rid="B129">2013</xref>). However, sequence similarity between the isoforms may complicate knockdown experiments using antisense strategies and the production of reliable antibodies. Finally, zebrafish, like flies and mice, are not human. Nonetheless, the flexibility of the fish model makes it potentially useful as a first-line indicator of individual mutations and a vehicle for the development of personalized therapies.</p>
</sec>
<sec id="s7">
<title>Conclusions</title>
<p>Whole-exome sequencing is bringing new Ca<sub>V</sub>2.1 mutations out of the woodwork (see Damaj et al., <xref ref-type="bibr" rid="B24">2015</xref>; Jiang et al., <xref ref-type="bibr" rid="B57">2016</xref>; Weyhrauch et al., <xref ref-type="bibr" rid="B130">2016</xref>; Luo et al., <xref ref-type="bibr" rid="B72">2017</xref>; Travaglini et al., <xref ref-type="bibr" rid="B116">2017</xref>). Many of the syndromes caused by these point mutations are more severe than the typical EA2 and FHM1 in that they present with not only ataxia or migraine but also with neurodevelopmental delay, nystagmus, epilepsy, cerebellar degeneration, hypotonia, and cognitive dysfunction. Modeling these more severe disorders is problematic because of the heterogeneous effects on channel function and the limitations intrinsic to flies and mice. Although not without some disadvantages, zebrafish present a useful model system for the timely characterization of pathological phenotypes and pharmacological correction.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>ST, AR, and RB wrote the article. All authors read and approved the final manuscript.</p>
</sec>
<sec id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by National Institute of Neurological Disorders and Stroke/National Institute of Health (NIH) grants NS103777 and NS086839 to RB and AR, respectively. ST was supported by the Boettcher Foundation.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>P. J.</given-names></name><name><surname>Garcia</surname><given-names>E.</given-names></name><name><surname>David</surname><given-names>L. S.</given-names></name><name><surname>Mulatz</surname><given-names>K. J.</given-names></name><name><surname>Spacey</surname><given-names>S. D.</given-names></name><name><surname>Snutch</surname><given-names>T. P.</given-names></name></person-group> (<year>2009</year>). <article-title>Ca<sub>V</sub>2.1 P/Q-type calcium channel alternative splicing affects the functional impact of familial hemiplegic migraine mutations: implications for calcium channelopathies</article-title>. <source/>Channels
<volume>3</volume>, <fpage>110</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.4161/chan.3.2.7932</pub-id><pub-id pub-id-type="pmid">19242091</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>S. K.</given-names></name><name><surname>MacKinnon</surname><given-names>R.</given-names></name></person-group> (<year>1996</year>). <article-title>Contribution of the S4 segment to gating charge in the Shaker K<sup>+</sup> channel</article-title>. <source/>Neuron
<volume>16</volume>, <fpage>1169</fpage>–<lpage>1177</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(00)80143-9</pub-id><pub-id pub-id-type="pmid">8663993</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>I.</given-names></name><name><surname>Barros</surname><given-names>J.</given-names></name><name><surname>Tuna</surname><given-names>A.</given-names></name><name><surname>Seixas</surname><given-names>A.</given-names></name><name><surname>Coutinho</surname><given-names>P.</given-names></name><name><surname>Sequeiros</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>A novel R1347Q mutation in the predicted voltage sensor segment of the P/Q-type calcium-channel α-subunit in a family with progressive cerebellar ataxia and hemiplegic migraine</article-title>. <source/>Clin. Genet.
<volume>65</volume>, <fpage>70</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1111/j..2004.00187.x</pub-id><pub-id pub-id-type="pmid">15032980</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Althobaiti</surname><given-names>Y. S.</given-names></name><name><surname>Almalki</surname><given-names>A.</given-names></name><name><surname>Alsaab</surname><given-names>H.</given-names></name><name><surname>Alsanie</surname><given-names>W.</given-names></name><name><surname>Gaber</surname><given-names>A.</given-names></name><name><surname>Alhadidi</surname><given-names>Q.</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>Pregabalin: potential for addiction and a possible glutamatergic mechanism</article-title>. <source/>Sci. Rep.
<volume>9</volume>:<fpage>15136</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-51556-4</pub-id><pub-id pub-id-type="pmid">31641170</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahamonde</surname><given-names>M. I.</given-names></name><name><surname>Serra</surname><given-names>S. A.</given-names></name><name><surname>Drechsel</surname><given-names>O.</given-names></name><name><surname>Rahman</surname><given-names>R.</given-names></name><name><surname>Marcé-Grau</surname><given-names>A.</given-names></name><name><surname>Prieto</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>A single amino acid deletion (ΔF1502) in the S6 segment of Ca<sub>V</sub>2.1 domain III associated with congenital ataxia increases channel activity and promotes Ca<sup>2+</sup> influx</article-title>. <source/>PLoS One
<volume>10</volume>:<fpage>e0146035</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0146035</pub-id><pub-id pub-id-type="pmid">26716990</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battistini</surname><given-names>S.</given-names></name><name><surname>Stenirri</surname><given-names>S.</given-names></name><name><surname>Piatti</surname><given-names>M.</given-names></name><name><surname>Gelfi</surname><given-names>C.</given-names></name><name><surname>Righetti</surname><given-names>P. G.</given-names></name><name><surname>Rocchi</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>A new <italic>CACNA1A</italic> gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia</article-title>. <source/>Neurology
<volume>53</volume>, <fpage>38</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.53.1.38</pub-id><pub-id pub-id-type="pmid">10408534</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beqollari</surname><given-names>D.</given-names></name><name><surname>Dockstader</surname><given-names>K.</given-names></name><name><surname>Bannister</surname><given-names>R. A.</given-names></name></person-group> (<year>2018</year>). <article-title>A skeletal muscle L-type Ca<sup>2+</sup> channel with a single mutation in the selectivity filter (Ca<sub>V</sub>1.1 E1014K) conducts K<sup>+</sup></article-title>. <source/>J. Biol. Chem.
<volume>293</volume>, <fpage>3126</fpage>–<lpage>3133</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M117.812446</pub-id><pub-id pub-id-type="pmid">29326166</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertholon</surname><given-names>P.</given-names></name><name><surname>Chabrier</surname><given-names>S.</given-names></name><name><surname>Riant</surname><given-names>F.</given-names></name><name><surname>Tournier-Lasserve</surname><given-names>E.</given-names></name><name><surname>Peyron</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Episodic ataxia type 2: unusual aspects in clinical and genetic presentation</article-title>. <source/>J. Neurol. Neurosurg. Psychiatry
<volume>80</volume>, <fpage>1289</fpage>–<lpage>1292</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.2008.159103</pub-id><pub-id pub-id-type="pmid">19864665</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumkin</surname><given-names>L.</given-names></name><name><surname>Michelson</surname><given-names>M.</given-names></name><name><surname>Leshinsky-Silver</surname><given-names>E.</given-names></name><name><surname>Kivity</surname><given-names>S.</given-names></name><name><surname>Lev</surname><given-names>D.</given-names></name><name><surname>Lerman-Sagie</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Congenital ataxia, mental retardation and dyskinesia associated with a novel <italic>CACNA1A</italic> mutation</article-title>. <source/>J. Child Neurol.
<volume>25</volume>, <fpage>892</fpage>–<lpage>897</lpage>. <pub-id pub-id-type="doi">10.1177/0883073809351316</pub-id><pub-id pub-id-type="pmid">20097664</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnet</surname><given-names>U.</given-names></name><name><surname>Richter</surname><given-names>E. L.</given-names></name><name><surname>Isbruch</surname><given-names>K.</given-names></name><name><surname>Scherbaum</surname><given-names>N.</given-names></name></person-group> (<year>2018</year>). <article-title>On the addictive power of gabapentinoids: a mini-review</article-title>. <source/>Psychiatr. Danub.
<volume>30</volume>, <fpage>142</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.24869/psyd.2018.142</pub-id><pub-id pub-id-type="pmid">29930223</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brusich</surname><given-names>D. J.</given-names></name><name><surname>Spring</surname><given-names>A. M.</given-names></name><name><surname>James</surname><given-names>T. D.</given-names></name><name><surname>Yeates</surname><given-names>C. J.</given-names></name><name><surname>Helms</surname><given-names>T. H.</given-names></name><name><surname>Frank</surname><given-names>C. A.</given-names></name></person-group> (<year>2018</year>). <article-title><italic>Drosophila</italic> Ca<sub>V</sub>2 channels harboring human migraine mutations cause synapse hyperexcitability that can be suppressed by inhibition of a Ca<sup>2+</sup> store release pathway</article-title>. <source/>PLoS Genet.
<volume>14</volume>:<fpage>e1007577</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1007577</pub-id><pub-id pub-id-type="pmid">30080864</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buraei</surname><given-names>Z.</given-names></name><name><surname>Schofield</surname><given-names>G.</given-names></name><name><surname>Elmslie</surname><given-names>K. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Roscovitine differentially affects Ca<sub>V</sub>2 and K<sub>V</sub> channels by binding to the open state</article-title>. <source/>Neuropharmacology
<volume>52</volume>, <fpage>883</fpage>–<lpage>894</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2006.10.006</pub-id><pub-id pub-id-type="pmid">17125805</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campiglio</surname><given-names>M.</given-names></name><name><surname>Flucher</surname><given-names>B. E.</given-names></name></person-group> (<year>2015</year>). <article-title>The role of auxiliary subunits for the functional diversity of voltage-gated calcium channels</article-title>. <source/>J. Cell. Physiol.
<volume>230</volume>, <fpage>2019</fpage>–<lpage>2031</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.24998</pub-id><pub-id pub-id-type="pmid">25820299</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y. Q.</given-names></name><name><surname>Piedras-Rentería</surname><given-names>E. S.</given-names></name><name><surname>Smith</surname><given-names>G. B.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Harata</surname><given-names>N. C.</given-names></name><name><surname>Tsien</surname><given-names>R. W.</given-names></name></person-group> (<year>2004</year>). <article-title>Presynaptic Ca<sup>2+</sup> channels compete for channel type-preferring slots in altered neurotransmission arising from Ca<sup>2+</sup> channelopathy</article-title>. <source/>Neuron
<volume>43</volume>, <fpage>387</fpage>–<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2004.07.014</pub-id><pub-id pub-id-type="pmid">15294146</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y. Q.</given-names></name><name><surname>Tsien</surname><given-names>R. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Different relationship of N- and P/Q-type Ca<sup>2+</sup> channels to channel-interacting slots in controlling neurotransmission at cultured hippocampal synapses</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>4536</fpage>–<lpage>4546</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.5161-09.2010</pub-id><pub-id pub-id-type="pmid">20357104</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreño</surname><given-names>O.</given-names></name><name><surname>Corominas</surname><given-names>R.</given-names></name><name><surname>Serra</surname><given-names>S. A.</given-names></name><name><surname>Sintas</surname><given-names>C.</given-names></name><name><surname>Fernández-Castillo</surname><given-names>N.</given-names></name><name><surname>Vila-Pueyo</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Screening of <italic>CACNA1A</italic> and <italic>ATP1A2</italic> genes in hemiplegic migraine: clinical, genetic, and functional studies</article-title>. <source/>Mol. Genet. Genomic Med.
<volume>1</volume>, <fpage>206</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1002/mgg3.24</pub-id><pub-id pub-id-type="pmid">24498617</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrera</surname><given-names>P.</given-names></name><name><surname>Piatti</surname><given-names>M.</given-names></name><name><surname>Stenirri</surname><given-names>S.</given-names></name><name><surname>Grimaldi</surname><given-names>L. M.</given-names></name><name><surname>Marchioni</surname><given-names>E.</given-names></name><name><surname>Curcio</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Genetic heterogeneity in Italian families with familial hemiplegic migraine</article-title>. <source/>Neurology
<volume>53</volume>, <fpage>26</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.53.1.26</pub-id><pub-id pub-id-type="pmid">10408532</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>W. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Ion channel voltage sensors: structure, function, and pathophysiology</article-title>. <source/>Neuron
<volume>67</volume>, <fpage>915</fpage>–<lpage>928</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.08.021</pub-id><pub-id pub-id-type="pmid">20869590</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>K. D.</given-names></name><name><surname>Kim</surname><given-names>J. S.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Jung</surname><given-names>I.</given-names></name><name><surname>Jeong</surname><given-names>S.-H.</given-names></name><name><surname>Lee</surname><given-names>S.-H.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Genetic variants associated with episodic ataxia in Korea</article-title>. <source/>Sci. Rep.
<volume>7</volume>:<fpage>13855</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-14254-7</pub-id><pub-id pub-id-type="pmid">29062094</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cricchi</surname><given-names>F.</given-names></name><name><surname>Di Lorenzo</surname><given-names>C.</given-names></name><name><surname>Grieco</surname><given-names>G. S.</given-names></name><name><surname>Rengo</surname><given-names>C.</given-names></name><name><surname>Cardinale</surname><given-names>A.</given-names></name><name><surname>Racaniello</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Early-onset progressive ataxia associated with the first <italic>CACNA1A</italic> mutation identified within the I-II loop</article-title>. <source/>J. Neurol. Sci.
<volume>254</volume>, <fpage>69</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2007.01.008</pub-id><pub-id pub-id-type="pmid">17292920</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuenca-León</surname><given-names>E.</given-names></name><name><surname>Banchs</surname><given-names>I.</given-names></name><name><surname>Serra</surname><given-names>S. A.</given-names></name><name><surname>Latorre</surname><given-names>P.</given-names></name><name><surname>Fernàndez-Castillo</surname><given-names>N.</given-names></name><name><surname>Corominas</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the <italic>CACNA1A</italic> gene</article-title>. <source/>J. Neurol. Sci.
<volume>280</volume>, <fpage>10</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2009.01.005</pub-id><pub-id pub-id-type="pmid">19232643</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuenca-León</surname><given-names>E.</given-names></name><name><surname>Corominas</surname><given-names>R.</given-names></name><name><surname>Fernàndez-Castillo</surname><given-names>N.</given-names></name><name><surname>Volpini</surname><given-names>V.</given-names></name><name><surname>Del Toro</surname><given-names>M.</given-names></name><name><surname>Roig</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Genetic analysis of 27 Spanish patients with hemiplegic migraine, basilar-type migraine and childhood periodic syndromes</article-title>. <source/>Cephalalgia
<volume>28</volume>, <fpage>1039</fpage>–<lpage>1047</lpage>. <pub-id pub-id-type="doi">10.1111/j.1468-2982.2008.01645.x</pub-id><pub-id pub-id-type="pmid">18644040</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahimene</surname><given-names>S.</given-names></name><name><surname>Page</surname><given-names>K. M.</given-names></name><name><surname>Nieto-Rostro</surname><given-names>M.</given-names></name><name><surname>Pratt</surname><given-names>W. S.</given-names></name><name><surname>D’Arco</surname><given-names>M.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group> (<year>2016</year>). <article-title>A Ca<sub>V</sub>2.1 N-terminal fragment relieves the dominant-negative inhibition by an episodic ataxia 2 mutant</article-title>. <source/>Neurobiol. Dis.
<volume>93</volume>, <fpage>243</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2016.05.020</pub-id><pub-id pub-id-type="pmid">27260834</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damaj</surname><given-names>L.</given-names></name><name><surname>Lupien-Meilleur</surname><given-names>A.</given-names></name><name><surname>Lortie</surname><given-names>A.</given-names></name><name><surname>Riou</surname><given-names>É.</given-names></name><name><surname>Ospina</surname><given-names>L. H.</given-names></name><name><surname>Gagnon</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title><italic>CACNA1A</italic> haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms</article-title>. <source/>Eur. J. Hum. Genet.
<volume>23</volume>, <fpage>1505</fpage>–<lpage>1512</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2015.21</pub-id><pub-id pub-id-type="pmid">25735478</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denier</surname><given-names>C.</given-names></name><name><surname>Ducros</surname><given-names>A.</given-names></name><name><surname>Durr</surname><given-names>A.</given-names></name><name><surname>Eymard</surname><given-names>B.</given-names></name><name><surname>Chassande</surname><given-names>B.</given-names></name><name><surname>Tournier-Lasserve</surname><given-names>E.</given-names></name></person-group> (<year>2001</year>). <article-title>Missense <italic>CACNA1A</italic> mutation causing episodic ataxia type 2</article-title>. <source/>Arch. Neurol.
<volume>58</volume>, <fpage>292</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.58.2.292</pub-id><pub-id pub-id-type="pmid">11176968</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Guilmi</surname><given-names>M. N.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Inchauspe</surname><given-names>C. G.</given-names></name><name><surname>Forsythe</surname><given-names>I. D.</given-names></name><name><surname>Ferrari</surname><given-names>M. D.</given-names></name><name><surname>van den Maagdenberg</surname><given-names>A. M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Synaptic gain-of-function effects of mutant Ca<sub>V</sub>2.1 channels in a mouse model of familial hemiplegic migraine are due to increased basal [Ca<sup>2+</sup>]<sub>i</sub></article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>7047</fpage>–<lpage>7058</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2526-13.2014</pub-id><pub-id pub-id-type="pmid">24849341</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dichgans</surname><given-names>M.</given-names></name><name><surname>Herzog</surname><given-names>J.</given-names></name><name><surname>Freilinger</surname><given-names>T.</given-names></name><name><surname>Wilke</surname><given-names>M.</given-names></name><name><surname>Auer</surname><given-names>D. P.</given-names></name></person-group> (<year>2005</year>). <article-title>1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1</article-title>. <source/>Neurology
<volume>64</volume>, <fpage>608</fpage>–<lpage>613</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000151855.98318.50</pub-id><pub-id pub-id-type="pmid">15728280</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Voltage-gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacology</article-title>. <source/>J. Physiol.
<volume>594</volume>, <fpage>5369</fpage>–<lpage>5390</lpage>. <pub-id pub-id-type="doi">10.1113/jp272262</pub-id><pub-id pub-id-type="pmid">27273705</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ducros</surname><given-names>A.</given-names></name><name><surname>Denier</surname><given-names>C.</given-names></name><name><surname>Joutel</surname><given-names>A.</given-names></name><name><surname>Cecillon</surname><given-names>M.</given-names></name><name><surname>Lescoat</surname><given-names>C.</given-names></name><name><surname>Vahedi</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel</article-title>. <source/>N. Engl. J. Med.
<volume>345</volume>, <fpage>17</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1056/nejm200107053450103</pub-id><pub-id pub-id-type="pmid">11439943</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunlap</surname><given-names>K.</given-names></name><name><surname>Luebke</surname><given-names>J. I.</given-names></name><name><surname>Turner</surname><given-names>T. J.</given-names></name></person-group> (<year>1994</year>). <article-title>Identification of calcium channels that control neurosecretion</article-title>. <source/>Science
<volume>266</volume>, <fpage>828</fpage>–<lpage>830</lpage>. <pub-id pub-id-type="doi">10.1126/science.266.5186.828-a</pub-id><pub-id pub-id-type="pmid">7973643</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunlap</surname><given-names>K.</given-names></name><name><surname>Luebke</surname><given-names>J. I.</given-names></name><name><surname>Turner</surname><given-names>T. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Exocytotic Ca<sup>2+</sup> channels in mammalian central neurons</article-title>. <source/>Trends Neurosci.
<volume>18</volume>, <fpage>89</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/0166-2236(95)80030-6</pub-id><pub-id pub-id-type="pmid">7537420</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliot</surname><given-names>M. A.</given-names></name><name><surname>Peroutka</surname><given-names>S. J.</given-names></name><name><surname>Welch</surname><given-names>S.</given-names></name><name><surname>May</surname><given-names>E. F.</given-names></name></person-group> (<year>1996</year>). <article-title>Familial hemiplegic migraine, nystagmus, and cerebellar atrophy</article-title>. <source/>Ann. Neurol.
<volume>39</volume>, <fpage>100</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410390115</pub-id><pub-id pub-id-type="pmid">8572654</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Epi4K Consortium</collab><collab>Epilepsy Phenome/Genome Project</collab></person-group>. (<year>2013</year>). <article-title><italic>De novo</italic> mutations in epileptic encephalopathies</article-title>. <source/>Nature
<volume>501</volume>, <fpage>217</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1038/nature12439</pub-id><pub-id pub-id-type="pmid">23934111</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filosa</surname><given-names>J. A.</given-names></name><name><surname>Bonev</surname><given-names>A. D.</given-names></name><name><surname>Straub</surname><given-names>S. V.</given-names></name><name><surname>Meredith</surname><given-names>A. L.</given-names></name><name><surname>Wilkerson</surname><given-names>M. K.</given-names></name><name><surname>Aldrich</surname><given-names>R. W.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Local potassium signaling couples neuronal activity to vasodilation in the brain</article-title>. <source/>Nat. Neurosci.
<volume>9</volume>, <fpage>1397</fpage>–<lpage>1403</lpage>. <pub-id pub-id-type="doi">10.1038/nn1779</pub-id><pub-id pub-id-type="pmid">17013381</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freilinger</surname><given-names>T.</given-names></name><name><surname>Ackl</surname><given-names>N.</given-names></name><name><surname>Ebert</surname><given-names>A.</given-names></name><name><surname>Schmidt</surname><given-names>C.</given-names></name><name><surname>Rautenstrauss</surname><given-names>B.</given-names></name><name><surname>Dichgans</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>A novel mutation in <italic>CACNA1A</italic> associated with hemiplegic migraine, cerebellar dysfunction and late-onset cognitive decline</article-title>. <source/>J. Neurol. Sci.
<volume>300</volume>, <fpage>160</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2010.09.032</pub-id><pub-id pub-id-type="pmid">21035146</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friend</surname><given-names>K. L.</given-names></name><name><surname>Crimmins</surname><given-names>D.</given-names></name><name><surname>Phan</surname><given-names>T. G.</given-names></name><name><surname>Sue</surname><given-names>C. M.</given-names></name><name><surname>Colley</surname><given-names>A.</given-names></name><name><surname>Fung</surname><given-names>V. S.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Detection of a novel missense mutation and second recurrent mutation in the <italic>CACNA1A</italic> gene in individuals with EA-2 and FHM</article-title>. <source/>Hum. Genet.
<volume>105</volume>, <fpage>261</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1007/s004390051099</pub-id><pub-id pub-id-type="pmid">10987655</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frontali</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Spinocerebellar ataxia type 6: channelopathy or glutamine repeat disorder?</article-title>
<source/>Brain Res. Bull.
<volume>56</volume>, <fpage>227</fpage>–<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1016/s0361-9230(01)00574-3</pub-id><pub-id pub-id-type="pmid">11719255</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Z.</given-names></name><name><surname>Todorov</surname><given-names>B.</given-names></name><name><surname>Barrett</surname><given-names>C. F.</given-names></name><name><surname>van Dorp</surname><given-names>S.</given-names></name><name><surname>Ferrari</surname><given-names>M. D.</given-names></name><name><surname>van den Maagdenberg</surname><given-names>A. M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Cerebellar ataxia by enhanced Ca<sub>V</sub>2.1 currents is alleviated by Ca<sup>2+</sup>-dependent K<sup>+</sup>-channel activators in <italic>CACNA1A</italic>(S218L) mutant mice</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>15533</fpage>–<lpage>15546</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2454-12.2012</pub-id><pub-id pub-id-type="pmid">23115190</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García</surname><given-names>K. D.</given-names></name><name><surname>Beam</surname><given-names>K. G.</given-names></name></person-group> (<year>1996</year>). <article-title>Reduction of calcium currents by Lambert-Eaton syndrome sera: motoneurons are preferentially affected, and L-type currents are spared</article-title>. <source/>J. Neurosci.
<volume>16</volume>, <fpage>4903</fpage>–<lpage>4913</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.16-16-04903.1996</pub-id><pub-id pub-id-type="pmid">8756422</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garza-López</surname><given-names>E.</given-names></name><name><surname>González-Ramírez</surname><given-names>R.</given-names></name><name><surname>Gandini</surname><given-names>M. A.</given-names></name><name><surname>Sandoval</surname><given-names>A.</given-names></name><name><surname>Felix</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>The familial hemiplegic migraine type 1 mutation K1336E affects direct G protein-mediated regulation of neuronal P/Q-type Ca<sup>2+</sup> channels</article-title>. <source/>Cephalalgia
<volume>33</volume>, <fpage>398</fpage>–<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1177/0333102412475236</pub-id><pub-id pub-id-type="pmid">23430985</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garza-López</surname><given-names>E.</given-names></name><name><surname>Sandoval</surname><given-names>A.</given-names></name><name><surname>González-Ramírez</surname><given-names>R.</given-names></name><name><surname>Gandini</surname><given-names>M. A.</given-names></name><name><surname>van den Maagdenberg</surname><given-names>A.</given-names></name><name><surname>De Waard</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Familial hemiplegic migraine type 1 mutations W1684R and V1696I alter G protein-mediated regulation of Ca<sub>V</sub>2.1 voltage-gated calcium channels</article-title>. <source/>Biochim. Biophys. Acta.
<volume>1822</volume>, <fpage>1238</fpage>–<lpage>1246</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2012.04.008</pub-id><pub-id pub-id-type="pmid">22549042</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granato</surname><given-names>M.</given-names></name><name><surname>van Eeden</surname><given-names>F. J.</given-names></name><name><surname>Schach</surname><given-names>U.</given-names></name><name><surname>Trowe</surname><given-names>T.</given-names></name><name><surname>Brand</surname><given-names>M.</given-names></name><name><surname>Furutani-Seiki</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva</article-title>. <source/>Development
<volume>123</volume>, <fpage>399</fpage>–<lpage>413</lpage>. <pub-id pub-id-type="pmid">9007258</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grieco</surname><given-names>G. S.</given-names></name><name><surname>Gagliardi</surname><given-names>S.</given-names></name><name><surname>Ricca</surname><given-names>I.</given-names></name><name><surname>Pansarasa</surname><given-names>O.</given-names></name><name><surname>Neri</surname><given-names>M.</given-names></name><name><surname>Gualandi</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>New <italic>CACNA1A</italic> deletions are associated to migraine phenotypes</article-title>. <source/>J. Headache Pain
<volume>19</volume>:<fpage>75</fpage>. <pub-id pub-id-type="doi">10.1186/s10194-018-0891-x</pub-id><pub-id pub-id-type="pmid">30167989</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>A.</given-names></name><name><surname>Hamling</surname><given-names>K. R.</given-names></name><name><surname>Knupp</surname><given-names>K.</given-names></name><name><surname>Hong</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>L. P.</given-names></name><name><surname>Baraban</surname><given-names>S. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome</article-title>. <source/>Brain
<volume>140</volume>, <fpage>669</fpage>–<lpage>683</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aww342</pub-id><pub-id pub-id-type="pmid">28073790</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerin</surname><given-names>A. A.</given-names></name><name><surname>Feigenbaum</surname><given-names>A.</given-names></name><name><surname>Donner</surname><given-names>E. J.</given-names></name><name><surname>Yoon</surname><given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>Stepwise developmental regression associated with novel <italic>CACNA1A</italic> mutation</article-title>. <source/>Pediatr. Neurol.
<volume>39</volume>, <fpage>363</fpage>–<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2008.07.030</pub-id><pub-id pub-id-type="pmid">18940563</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guida</surname><given-names>S.</given-names></name><name><surname>Trettel</surname><given-names>F.</given-names></name><name><surname>Pagnutti</surname><given-names>S.</given-names></name><name><surname>Mantuano</surname><given-names>E.</given-names></name><name><surname>Tottene</surname><given-names>A.</given-names></name><name><surname>Veneziano</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Complete loss of P/Q calcium channel activity caused by a <italic>CACNA1A</italic> missense mutation carried by patients with episodic ataxia type 2</article-title>. <source/>Am. J. Hum. Genet.
<volume>68</volume>, <fpage>759</fpage>–<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1086/318804</pub-id><pub-id pub-id-type="pmid">11179022</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hans</surname><given-names>M.</given-names></name><name><surname>Luvisetto</surname><given-names>S.</given-names></name><name><surname>Williams</surname><given-names>M. E.</given-names></name><name><surname>Spagnolo</surname><given-names>M.</given-names></name><name><surname>Urrutia</surname><given-names>A.</given-names></name><name><surname>Tottene</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Functional consequences of mutations in the human α<sub>1A</sub> calcium channel subunit linked to familial hemiplegic migraine</article-title>. <source/>J. Neurosci.
<volume>19</volume>, <fpage>1610</fpage>–<lpage>1619</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-05-01610.1999</pub-id><pub-id pub-id-type="pmid">10024348</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hering</surname><given-names>S.</given-names></name><name><surname>Zangerl-Plessl</surname><given-names>E. M.</given-names></name><name><surname>Beyl</surname><given-names>S.</given-names></name><name><surname>Hohaus</surname><given-names>A.</given-names></name><name><surname>Andranovits</surname><given-names>S.</given-names></name><name><surname>Timin</surname><given-names>E. N.</given-names></name></person-group> (<year>2018</year>). <article-title>Calcium channel gating</article-title>. <source/>Pflugers Arch.
<volume>470</volume>, <fpage>1291</fpage>–<lpage>1309</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-018-2163-7</pub-id><pub-id pub-id-type="pmid">29951751</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imbrici</surname><given-names>P.</given-names></name><name><surname>Jaffe</surname><given-names>S. L.</given-names></name><name><surname>Eunson</surname><given-names>L. H.</given-names></name><name><surname>Davies</surname><given-names>N. P.</given-names></name><name><surname>Herd</surname><given-names>C.</given-names></name><name><surname>Robertson</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Dysfunction of the brain calcium channel Ca<sub>V</sub>2.1 in absence epilepsy and episodic ataxia</article-title>. <source/>Brain
<volume>127</volume>, <fpage>2682</fpage>–<lpage>2692</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awh301</pub-id><pub-id pub-id-type="pmid">15483044</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Indelicato</surname><given-names>E.</given-names></name><name><surname>Nachbauer</surname><given-names>W.</given-names></name><name><surname>Karner</surname><given-names>E.</given-names></name><name><surname>Eigentler</surname><given-names>A.</given-names></name><name><surname>Wagner</surname><given-names>M.</given-names></name><name><surname>Unterberger</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>The neuropsychiatric phenotype in <italic>CACNA1A</italic> mutations: a retrospective single center study and review of the literature</article-title>. <source/>Eur. J. Neurol.
<volume>26</volume>, <fpage>66.e1</fpage>–<lpage>66.e7</lpage>. <pub-id pub-id-type="doi">10.1111/ene.13765</pub-id><pub-id pub-id-type="pmid">30063100</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaacs</surname><given-names>D. A.</given-names></name><name><surname>Bradshaw</surname><given-names>M. J.</given-names></name><name><surname>Brown</surname><given-names>K.</given-names></name><name><surname>Hedera</surname><given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>Case report of novel <italic>CACNA1A</italic> gene mutation causing episodic ataxia type 2</article-title>. <source/>SAGE Open Med. Case Rep.
<volume>5</volume>:<fpage>2050313X17706044</fpage>. <pub-id pub-id-type="doi">10.1177/2050313x17706044</pub-id><pub-id pub-id-type="pmid">28540055</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jen</surname><given-names>J. C.</given-names></name><name><surname>Graves</surname><given-names>T. D.</given-names></name><name><surname>Hess</surname><given-names>E. J.</given-names></name><name><surname>Hanna</surname><given-names>M. G.</given-names></name><name><surname>Griggs</surname><given-names>R. C.</given-names></name><name><surname>Baloh</surname><given-names>R. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Primary episodic ataxias: diagnosis, pathogenesis and treatment</article-title>. <source/>Brain
<volume>130</volume>, <fpage>2484</fpage>–<lpage>2493</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awm126</pub-id><pub-id pub-id-type="pmid">17575281</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jen</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>G. W.</given-names></name><name><surname>Baloh</surname><given-names>R. W.</given-names></name></person-group> (<year>2004</year>). <article-title>Clinical spectrum of episodic ataxia type 2</article-title>. <source/>Neurology
<volume>62</volume>, <fpage>17</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000101675.61074.50</pub-id><pub-id pub-id-type="pmid">14718690</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jen</surname><given-names>J.</given-names></name><name><surname>Wan</surname><given-names>J.</given-names></name><name><surname>Graves</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Mock</surname><given-names>A. F.</given-names></name><name><surname>Coulin</surname><given-names>C. J.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission</article-title>. <source/>Neurology
<volume>57</volume>, <fpage>1843</fpage>–<lpage>1848</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.57.10.1843</pub-id><pub-id pub-id-type="pmid">11723274</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeng</surname><given-names>C. J.</given-names></name><name><surname>Chen</surname><given-names>Y. T.</given-names></name><name><surname>Chen</surname><given-names>Y. W.</given-names></name><name><surname>Tang</surname><given-names>C. Y.</given-names></name></person-group> (<year>2006</year>). <article-title>Dominant-negative effects of human P/Q-type Ca<sup>2+</sup>channel mutations associated with episodic ataxia type 2</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>290</volume>, <fpage>C1209</fpage>–<lpage>C1220</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00247.2005</pub-id><pub-id pub-id-type="pmid">16306128</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeng</surname><given-names>C. J.</given-names></name><name><surname>Sun</surname><given-names>M. C.</given-names></name><name><surname>Chen</surname><given-names>Y. W.</given-names></name><name><surname>Tang</surname><given-names>C. Y.</given-names></name></person-group> (<year>2008</year>). <article-title>Dominant-negative effects of episodic ataxia type 2 mutations involve disruption of membrane trafficking of human P/Q-type Ca<sup>2+</sup> channels</article-title>. <source/>J. Cell. Physiol.
<volume>214</volume>, <fpage>422</fpage>–<lpage>433</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.21216</pub-id><pub-id pub-id-type="pmid">17654512</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X.</given-names></name><name><surname>Raju</surname><given-names>P. K.</given-names></name><name><surname>D’Avanzo</surname><given-names>N.</given-names></name><name><surname>Lachance</surname><given-names>M.</given-names></name><name><surname>Pepin</surname><given-names>J.</given-names></name><name><surname>Dubeau</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>Both gain-of-function and loss-of-function <italic>de novo</italic>
<italic>CACNA1A</italic> mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndrome</article-title>. <source/>Epilepsia
<volume>60</volume>, <fpage>1881</fpage>–<lpage>1894</lpage>. <pub-id pub-id-type="doi">10.1111/epi.16316</pub-id><pub-id pub-id-type="pmid">31468518</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H. S.</given-names></name><name><surname>Wang</surname><given-names>D. M.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Pan</surname><given-names>S. Y.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Missense mutation R1345Q in <italic>CACNA1A</italic> gene causes a new type of ataxia with episodic tremor: clinical features, genetic analysis and treatment in a familial case</article-title>. <source/>Nan Fang Yi Ke Da Xue Xue Bao
<volume>36</volume>, <fpage>883</fpage>–<lpage>886</lpage>. <pub-id pub-id-type="pmid">27435762</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jodice</surname><given-names>C.</given-names></name><name><surname>Mantuano</surname><given-names>E.</given-names></name><name><surname>Veneziano</surname><given-names>L.</given-names></name><name><surname>Trettel</surname><given-names>F.</given-names></name><name><surname>Sabbadini</surname><given-names>G.</given-names></name><name><surname>Calandriello</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the <italic>CACNA1A</italic> gene on chromosome 19p</article-title>. <source/>Hum. Mol. Genet.
<volume>6</volume>, <fpage>1973</fpage>–<lpage>1978</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/6.11.1973</pub-id><pub-id pub-id-type="pmid">9302278</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jun</surname><given-names>K.</given-names></name><name><surname>Piedras-Rentería</surname><given-names>E. S.</given-names></name><name><surname>Smith</surname><given-names>S. M.</given-names></name><name><surname>Wheeler</surname><given-names>D. B.</given-names></name><name><surname>Lee</surname><given-names>S. B.</given-names></name><name><surname>Lee</surname><given-names>T. G.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Ablation of P/Q-type Ca<sup>2+</sup> channel currents, altered synaptic transmission and progressive ataxia in mice lacking the α<sub>1A</sub>-subunit</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>96</volume>, <fpage>15245</fpage>–<lpage>15250</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.26.15245</pub-id><pub-id pub-id-type="pmid">10611370</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaja</surname><given-names>S.</given-names></name><name><surname>Van de Ven</surname><given-names>R. C.</given-names></name><name><surname>Broos</surname><given-names>L. A.</given-names></name><name><surname>Frants</surname><given-names>R. R.</given-names></name><name><surname>Ferrari</surname><given-names>M. D.</given-names></name><name><surname>Van den Maagdenberg</surname><given-names>A. M.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Severe and progressive neurotransmitter release aberrations in familial hemiplegic migraine type 1 <italic>CACNA1A</italic> S218L knock-in mice</article-title>. <source/>J. Neurophysiol.
<volume>104</volume>, <fpage>1445</fpage>–<lpage>1455</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00012.2010</pub-id><pub-id pub-id-type="pmid">20631222</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaja</surname><given-names>S.</given-names></name><name><surname>van de Ven</surname><given-names>R. C.</given-names></name><name><surname>Broos</surname><given-names>L. A.</given-names></name><name><surname>Veldman</surname><given-names>H.</given-names></name><name><surname>van Dijk</surname><given-names>J. G.</given-names></name><name><surname>Verschuuren</surname><given-names>J. J.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Gene dosage-dependent transmitter release changes at neuromuscular synapses of <italic>CACNA1A</italic> R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness</article-title>. <source/>Neuroscience
<volume>135</volume>, <fpage>81</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.04.069</pub-id><pub-id pub-id-type="pmid">16111830</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>M. G.</given-names></name><name><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group> (<year>2003</year>). <article-title>γ subunit of voltage-activated calcium channels</article-title>. <source/>J. Biol. Chem.
<volume>278</volume>, <fpage>21315</fpage>–<lpage>21318</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R300004200</pub-id><pub-id pub-id-type="pmid">12676943</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knierim</surname><given-names>E.</given-names></name><name><surname>Leisle</surname><given-names>L.</given-names></name><name><surname>Wagner</surname><given-names>C.</given-names></name><name><surname>Weschke</surname><given-names>B.</given-names></name><name><surname>Lucke</surname><given-names>B.</given-names></name><name><surname>Bohner</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Recurrent stroke due to a novel voltage sensor mutation in Ca<sub>V</sub>2.1 responds to verapamil</article-title>. <source/>Stroke
<volume>42</volume>, <fpage>e14</fpage>–<lpage>e17</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.110.600023</pub-id><pub-id pub-id-type="pmid">21183743</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kors</surname><given-names>E. E.</given-names></name><name><surname>Melberg</surname><given-names>A.</given-names></name><name><surname>Vanmolkot</surname><given-names>K. R.</given-names></name><name><surname>Kumlien</surname><given-names>E.</given-names></name><name><surname>Haan</surname><given-names>J.</given-names></name><name><surname>Raininko</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia and a new <italic>CACNA1A</italic> mutation</article-title>. <source/>Neurology
<volume>63</volume>, <fpage>1136</fpage>–<lpage>1137</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000138571.48593.fc</pub-id><pub-id pub-id-type="pmid">15452324</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kors</surname><given-names>E. E.</given-names></name><name><surname>Terwindt</surname><given-names>G. M.</given-names></name><name><surname>Vermeulen</surname><given-names>F. L.</given-names></name><name><surname>Fitzsimons</surname><given-names>R. B.</given-names></name><name><surname>Jardine</surname><given-names>P. E.</given-names></name><name><surname>Heywood</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Delayed cerebral edema and fatal coma after minor head trauma: role of the <italic>CACNA1A</italic> calcium channel subunit gene and relationship with familial hemiplegic migraine</article-title>. <source/>Ann. Neurol.
<volume>49</volume>, <fpage>753</fpage>–<lpage>760</lpage>. <pub-id pub-id-type="doi">10.1002/ana.1031</pub-id><pub-id pub-id-type="pmid">11409427</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C. S.</given-names></name><name><surname>Dagnino-Acosta</surname><given-names>A.</given-names></name><name><surname>Yarotskyy</surname><given-names>V.</given-names></name><name><surname>Hanna</surname><given-names>A.</given-names></name><name><surname>Lyfenko</surname><given-names>A.</given-names></name><name><surname>Knoblauch</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Ca<sup>2+</sup> permeation and/or binding to Ca<sub>V</sub>1.1 fine-tunes skeletal muscle Ca<sup>2+</sup> signaling to sustain muscle function</article-title>. <source/>Skelet. Muscle.
<volume>5</volume>:<fpage>4</fpage>. <pub-id pub-id-type="doi">10.1186/s13395-014-0027-1</pub-id><pub-id pub-id-type="pmid">25717360</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letts</surname><given-names>V. A.</given-names></name><name><surname>Felix</surname><given-names>R.</given-names></name><name><surname>Biddlecome</surname><given-names>G. H.</given-names></name><name><surname>Arikkath</surname><given-names>J.</given-names></name><name><surname>Mahaffey</surname><given-names>C. L.</given-names></name><name><surname>Valenzuela</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>The mouse stargazer gene encodes a neuronal Ca<sup>2+</sup>-channel γ subunit</article-title>. <source/>Nat. Genet.
<volume>19</volume>, <fpage>340</fpage>–<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1038/1228</pub-id><pub-id pub-id-type="pmid">9697694</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llinás</surname><given-names>R.</given-names></name><name><surname>Steinberg</surname><given-names>I. Z.</given-names></name><name><surname>Walton</surname><given-names>K.</given-names></name></person-group> (<year>1981</year>). <article-title>Presynaptic calcium currents in squid giant synapse</article-title>. <source/>Biophys. J.
<volume>33</volume>, <fpage>289</fpage>–<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-3495(81)84898-9</pub-id><pub-id pub-id-type="pmid">7225510</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Low</surname><given-names>S. E.</given-names></name><name><surname>Woods</surname><given-names>I. G.</given-names></name><name><surname>Lachance</surname><given-names>M.</given-names></name><name><surname>Ryan</surname><given-names>J.</given-names></name><name><surname>Schier</surname><given-names>A. F.</given-names></name><name><surname>Saint-Amant</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Touch responsiveness in zebrafish requires voltage-gated calcium channel 2.1b</article-title>. <source/>J. Neurophysiol.
<volume>108</volume>, <fpage>148</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00839.2011</pub-id><pub-id pub-id-type="pmid">22490555</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>A.</given-names></name><name><surname>Flockerzi</surname><given-names>V.</given-names></name><name><surname>Hofmann</surname><given-names>F.</given-names></name></person-group> (<year>1997</year>). <article-title>Regional expression and cellular localization of the α<sub>1</sub> and βsubunit of high voltage-activated calcium channels in rat brain</article-title>. <source/>J. Neurosci.
<volume>17</volume>, <fpage>1339</fpage>–<lpage>1349</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-04-01339.1997</pub-id><pub-id pub-id-type="pmid">9006977</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Rosenfeld</surname><given-names>J. A.</given-names></name><name><surname>Yamamoto</surname><given-names>S.</given-names></name><name><surname>Harel</surname><given-names>T.</given-names></name><name><surname>Zuo</surname><given-names>Z.</given-names></name><name><surname>Hall</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Clinically severe <italic>CACNA1A</italic> alleles affect synaptic function and neurodegeneration differentially</article-title>. <source/>PLoS Genet.
<volume>13</volume>:<fpage>e1006905</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1006905</pub-id><pub-id pub-id-type="pmid">28742085</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maddison</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Treatment in Lambert-Eaton myasthenic syndrome</article-title>. <source/>Ann. N Y Acad. Sci.
<volume>1275</volume>, <fpage>78</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2012.06769.x</pub-id><pub-id pub-id-type="pmid">23278581</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maksemous</surname><given-names>N.</given-names></name><name><surname>Roy</surname><given-names>B.</given-names></name><name><surname>Smith</surname><given-names>R. A.</given-names></name><name><surname>Griffiths</surname><given-names>L. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Next-generation sequencing identifies novel <italic>CACNA1A</italic> gene mutations in episodic ataxia type 2</article-title>. <source/>Mol. Genet. Genomic Med.
<volume>4</volume>, <fpage>211</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1002/mgg3.196</pub-id><pub-id pub-id-type="pmid">27066515</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantuano</surname><given-names>E.</given-names></name><name><surname>Romano</surname><given-names>S.</given-names></name><name><surname>Veneziano</surname><given-names>L.</given-names></name><name><surname>Gellera</surname><given-names>C.</given-names></name><name><surname>Castellotti</surname><given-names>B.</given-names></name><name><surname>Caimi</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Identification of novel and recurrent <italic>CACNA1A</italic> gene mutations in fifteen patients with episodic ataxia type 2</article-title>. <source/>J. Neurol. Sci.
<volume>291</volume>, <fpage>30</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2010.01.010</pub-id><pub-id pub-id-type="pmid">20129625</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantuano</surname><given-names>E.</given-names></name><name><surname>Veneziano</surname><given-names>L.</given-names></name><name><surname>Spadaro</surname><given-names>M.</given-names></name><name><surname>Giunti</surname><given-names>P.</given-names></name><name><surname>Guida</surname><given-names>S.</given-names></name><name><surname>Leggio</surname><given-names>M. G.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Clusters of non-truncating mutations of P/Q type Ca<sup>2+</sup> channel subunit Ca<sub>V</sub>2.1 causing episodic ataxia 2</article-title>. <source/>J. Med. Genet.
<volume>41</volume>:<fpage>e82</fpage>. <pub-id pub-id-type="doi">10.1136/jmg.2003.015396</pub-id><pub-id pub-id-type="pmid">15173248</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melliti</surname><given-names>K.</given-names></name><name><surname>Grabner</surname><given-names>M.</given-names></name><name><surname>Seabrook</surname><given-names>G. R.</given-names></name></person-group> (<year>2003</year>). <article-title>The familial hemiplegic migraine mutation R192Q reduces G-protein-mediated inhibition of P/Q-type (Ca<sub>V</sub>2.1) calcium channels expressed in human embryonic kidney cells</article-title>. <source/>J. Physiol.
<volume>546</volume>, <fpage>337</fpage>–<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2002.026716</pub-id><pub-id pub-id-type="pmid">12527722</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melzer</surname><given-names>N.</given-names></name><name><surname>Classen</surname><given-names>J.</given-names></name><name><surname>Reiners</surname><given-names>K.</given-names></name><name><surname>Buttmann</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Fluctuating neuromuscular transmission defects and inverse acetazolamide response in episodic ataxia type 2 associated with the novel Ca<sub>V</sub>2.1 single amino acid substitution R2090Q</article-title>. <source/>J. Neurol. Sci.
<volume>296</volume>, <fpage>104</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2010.06.024</pub-id><pub-id pub-id-type="pmid">20663518</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mezghrani</surname><given-names>A.</given-names></name><name><surname>Monteil</surname><given-names>A.</given-names></name><name><surname>Watschinger</surname><given-names>K.</given-names></name><name><surname>Sinnegger-Brauns</surname><given-names>M. J.</given-names></name><name><surname>Barrère</surname><given-names>C.</given-names></name><name><surname>Bourinet</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>A destructive interaction mechanism accounts for dominant-negative effects of misfolded mutants of voltage-gated calcium channels</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>4501</fpage>–<lpage>4511</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2844-07.2008</pub-id><pub-id pub-id-type="pmid">18434528</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miki</surname><given-names>T.</given-names></name><name><surname>Zwingman</surname><given-names>T. A.</given-names></name><name><surname>Wakamori</surname><given-names>M.</given-names></name><name><surname>Lutz</surname><given-names>C. M.</given-names></name><name><surname>Cook</surname><given-names>S. A.</given-names></name><name><surname>Hosford</surname><given-names>D. A.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Two novel alleles of tottering with distinct Ca<sub>V</sub>2.1 calcium channel neuropathologies</article-title>. <source/>Neuroscience
<volume>155</volume>, <fpage>31</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.05.028</pub-id><pub-id pub-id-type="pmid">18597946</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>Y.</given-names></name><name><surname>Friedrich</surname><given-names>T.</given-names></name><name><surname>Kim</surname><given-names>M. S.</given-names></name><name><surname>Mikami</surname><given-names>A.</given-names></name><name><surname>Nakai</surname><given-names>J.</given-names></name><name><surname>Ruth</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>Primary structure and functional expression from complementary DNA of a brain calcium channel</article-title>. <source/>Nature
<volume>350</volume>, <fpage>398</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1038/350398a0</pub-id><pub-id pub-id-type="pmid">1849233</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neely</surname><given-names>A.</given-names></name><name><surname>Hidalgo</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Structure-function of proteins interacting with the α<sub>1</sub> pore-forming subunit of high-voltage-activated calcium channels</article-title>. <source/>Front. Physiol.
<volume>5</volume>:<fpage>209</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2014.00209</pub-id><pub-id pub-id-type="pmid">24917826</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikaido</surname><given-names>K.</given-names></name><name><surname>Tachi</surname><given-names>N.</given-names></name><name><surname>Ohya</surname><given-names>K.</given-names></name><name><surname>Wada</surname><given-names>T.</given-names></name><name><surname>Tsutsumi</surname><given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>New mutation of <italic>CACNA1A</italic> gene in episodic ataxia type 2</article-title>. <source/>Pediatr. Int.
<volume>53</volume>, <fpage>415</fpage>–<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1111/j.1442-200x.2011.03390.x</pub-id><pub-id pub-id-type="pmid">21696515</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohba</surname><given-names>C.</given-names></name><name><surname>Osaka</surname><given-names>H.</given-names></name><name><surname>Iai</surname><given-names>M.</given-names></name><name><surname>Yamashita</surname><given-names>S.</given-names></name><name><surname>Suzuki</surname><given-names>Y.</given-names></name><name><surname>Aida</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood</article-title>. <source/>Neurogenetics
<volume>14</volume>, <fpage>225</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-013-0375-8</pub-id><pub-id pub-id-type="pmid">24091540</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ophoff</surname><given-names>R. A.</given-names></name><name><surname>Terwindt</surname><given-names>G. M.</given-names></name><name><surname>Vergouwe</surname><given-names>M. N.</given-names></name><name><surname>van Eijk</surname><given-names>R.</given-names></name><name><surname>Oefner</surname><given-names>P. J.</given-names></name><name><surname>Hoffman</surname><given-names>S. M.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca<sup>2+</sup> channel gene <italic>CACNL1A4</italic></article-title>. <source/>Cell
<volume>87</volume>, <fpage>543</fpage>–<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(00)81373-2</pub-id><pub-id pub-id-type="pmid">8898206</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>K. M.</given-names></name><name><surname>Heblich</surname><given-names>F.</given-names></name><name><surname>Davies</surname><given-names>A.</given-names></name><name><surname>Butcher</surname><given-names>A. J.</given-names></name><name><surname>Leroy</surname><given-names>J.</given-names></name><name><surname>Bertaso</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Dominant-negative calcium channel suppression by truncated constructs involves a kinase implicated in the unfolded protein response</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>5400</fpage>–<lpage>5409</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0553-04.2004</pub-id><pub-id pub-id-type="pmid">15190113</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>K. M.</given-names></name><name><surname>Heblich</surname><given-names>F.</given-names></name><name><surname>Margas</surname><given-names>W.</given-names></name><name><surname>Pratt</surname><given-names>W. S.</given-names></name><name><surname>Nieto-Rostro</surname><given-names>M.</given-names></name><name><surname>Chaggar</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>N terminus is key to the dominant negative suppression of Ca<sub>V</sub>2 calcium channels</article-title>. <source/>J. Biol. Chem.
<volume>285</volume>, <fpage>835</fpage>–<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.065045</pub-id><pub-id pub-id-type="pmid">19903821</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelzer</surname><given-names>N.</given-names></name><name><surname>Haan</surname><given-names>J.</given-names></name><name><surname>Stam</surname><given-names>A. H.</given-names></name><name><surname>Vijfhuizen</surname><given-names>L. S.</given-names></name><name><surname>Koelewijn</surname><given-names>S. C.</given-names></name><name><surname>Smagge</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation</article-title>. <source/>Neurology
<volume>90</volume>, <fpage>e575</fpage>–<lpage>e582</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0000000000004966</pub-id><pub-id pub-id-type="pmid">29343472</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrovicova</surname><given-names>A.</given-names></name><name><surname>Brozman</surname><given-names>M.</given-names></name><name><surname>Kurca</surname><given-names>E.</given-names></name><name><surname>Gobo</surname><given-names>T.</given-names></name><name><surname>Dluha</surname><given-names>J.</given-names></name><name><surname>Kalmarova</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Novel missense variant of <italic>CACNA1A</italic> gene in a Slovak family with episodic ataxia type 2</article-title>. <source/>Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub.
<volume>161</volume>, <fpage>107</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.5507/bp.2016.066</pub-id><pub-id pub-id-type="pmid">28096552</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietrobon</surname><given-names>D.</given-names></name></person-group> (<year>2007</year>). <article-title>Familial hemiplegic migraine</article-title>. <source/>Neurotherapeutics
<volume>4</volume>, <fpage>274</fpage>–<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1016/j.nurt.2007.01.008</pub-id><pub-id pub-id-type="pmid">17395138</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietrobon</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>Ca<sub>V</sub>2.1 channelopathies</article-title>. <source/>Pflugers Arch.
<volume>460</volume>, <fpage>375</fpage>–<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-010-0802-8</pub-id><pub-id pub-id-type="pmid">20204399</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pragnell</surname><given-names>M.</given-names></name><name><surname>De Waard</surname><given-names>M.</given-names></name><name><surname>Mori</surname><given-names>Y.</given-names></name><name><surname>Tanabe</surname><given-names>T.</given-names></name><name><surname>Snutch</surname><given-names>T. P.</given-names></name><name><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group> (<year>1994</year>). <article-title>Calcium channel β-subunit binds to a conserved motif in the I-II cytoplasmic linker of the α 1-subunit</article-title>. <source/>Nature
<volume>368</volume>, <fpage>67</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1038/368067a0</pub-id><pub-id pub-id-type="pmid">7509046</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajakulendran</surname><given-names>S.</given-names></name><name><surname>Graves</surname><given-names>T. D.</given-names></name><name><surname>Labrum</surname><given-names>R. W.</given-names></name><name><surname>Kotzadimitriou</surname><given-names>D.</given-names></name><name><surname>Eunson</surname><given-names>L.</given-names></name><name><surname>Davis</surname><given-names>M. B.</given-names></name><etal></etal></person-group>. (<year>2010a</year>). <article-title>Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy</article-title>. <source/>J. Physiol.
<volume>588</volume>, <fpage>1905</fpage>–<lpage>1913</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2009.186437</pub-id><pub-id pub-id-type="pmid">20156848</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajakulendran</surname><given-names>S.</given-names></name><name><surname>Schorge</surname><given-names>S.</given-names></name><name><surname>Kullmann</surname><given-names>D. M.</given-names></name><name><surname>Hanna</surname><given-names>M. G.</given-names></name></person-group> (<year>2010b</year>). <article-title>Dysfunction of the Ca<sub>V</sub>2.1 calcium channel in cerebellar ataxias</article-title>. <source/>F1000 Biol. Rep.
<volume>2</volume>:<fpage>4</fpage>. <pub-id pub-id-type="doi">10.3410/b2-4</pub-id><pub-id pub-id-type="pmid">20948794</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajakulendran</surname><given-names>S.</given-names></name><name><surname>Kaski</surname><given-names>D.</given-names></name><name><surname>Hanna</surname><given-names>M. G.</given-names></name></person-group> (<year>2012</year>). <article-title>Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS</article-title>. <source/>Nat. Rev. Neurol.
<volume>8</volume>, <fpage>86</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2011.228</pub-id><pub-id pub-id-type="pmid">22249839</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riant</surname><given-names>F.</given-names></name><name><surname>Ducros</surname><given-names>A.</given-names></name><name><surname>Ploton</surname><given-names>C.</given-names></name><name><surname>Barbance</surname><given-names>C.</given-names></name><name><surname>Depienne</surname><given-names>C.</given-names></name><name><surname>Tournier-Lasserve</surname><given-names>E.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>De novo</italic> mutations in <italic>ATP1A2</italic> and <italic>CACNA1A</italic> are frequent in early-onset sporadic hemiplegic migraine</article-title>. <source/>Neurology
<volume>75</volume>, <fpage>967</fpage>–<lpage>972</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0b013e3181f25e8f</pub-id><pub-id pub-id-type="pmid">20837964</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romaniello</surname><given-names>R.</given-names></name><name><surname>Zucca</surname><given-names>C.</given-names></name><name><surname>Tonelli</surname><given-names>A.</given-names></name><name><surname>Bonato</surname><given-names>S.</given-names></name><name><surname>Baschirotto</surname><given-names>C.</given-names></name><name><surname>Zanotta</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>A wide spectrum of clinical, neurophysiological and neuroradiological abnormalities in a family with a novel <italic>CACNA1A</italic> mutation</article-title>. <source/>J. Neurol. Neurosurg. Psychiatry
<volume>81</volume>, <fpage>840</fpage>–<lpage>843</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.2008.163402</pub-id><pub-id pub-id-type="pmid">20682717</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>S. J.</given-names></name><name><surname>Kriener</surname><given-names>L. H.</given-names></name><name><surname>Heinzer</surname><given-names>A. K.</given-names></name><name><surname>Fan</surname><given-names>X.</given-names></name><name><surname>Raike</surname><given-names>R. S.</given-names></name><name><surname>van den Maagdenberg</surname><given-names>A. M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>The first knockin mouse model of episodic ataxia type 2</article-title>. <source/>Exp. Neurol.
<volume>261</volume>, <fpage>553</fpage>–<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2014.08.001</pub-id><pub-id pub-id-type="pmid">25109669</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scoggan</surname><given-names>K. A.</given-names></name><name><surname>Friedman</surname><given-names>J. H.</given-names></name><name><surname>Bulman</surname><given-names>D. E.</given-names></name></person-group> (<year>2006</year>). <article-title><italic>CACNA1A</italic> mutation in a EA-2 patient responsive to acetazolamide and valproic acid</article-title>. <source/>Can. J. Neurol. Sci.
<volume>33</volume>, <fpage>68</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1017/s0317167100004728</pub-id><pub-id pub-id-type="pmid">16583725</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname><given-names>S. A.</given-names></name><name><surname>Cuenca-León</surname><given-names>E.</given-names></name><name><surname>Llobet</surname><given-names>A.</given-names></name><name><surname>Rubio-Moscardo</surname><given-names>F.</given-names></name><name><surname>Plata</surname><given-names>C.</given-names></name><name><surname>Carreño</surname><given-names>O.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>A mutation in the first intracellular loop of <italic>CACNA1A</italic> prevents P/Q channel modulation by SNARE proteins and lowers exocytosis</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>107</volume>, <fpage>1672</fpage>–<lpage>1677</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0908359107</pub-id><pub-id pub-id-type="pmid">20080591</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname><given-names>S.</given-names></name><name><surname>Fernàndez-Castillo</surname><given-names>N.</given-names></name><name><surname>Macaya</surname><given-names>A.</given-names></name><name><surname>Cormand</surname><given-names>B.</given-names></name><name><surname>Valverde</surname><given-names>B.</given-names></name><name><surname>Fernández-Fernández</surname><given-names>J. M.</given-names></name></person-group> (<year>2009</year>). <article-title>The hemiplegic migraine-associated Y1245C mutation in <italic>CACNA1A</italic> results in a gain of channel function due to its effect on the voltage sensor and G-protein-mediated inhibition</article-title>. <source/>Pflügers Arch.
<volume>458</volume>, <fpage>489</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-009-0637-3</pub-id><pub-id pub-id-type="pmid">19189122</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname><given-names>S. A.</given-names></name><name><surname>Gené</surname><given-names>G. G.</given-names></name><name><surname>Elorza-Vidal</surname><given-names>X.</given-names></name><name><surname>Fernández-Fernández</surname><given-names>J. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Cross talk between β subunits, intracellular Ca<sup>2+</sup> signaling, and SNAREs in the modulation of Ca<sub>V</sub>2.1 channel steady-state inactivation</article-title>. <source/>Physiol. Rep.
<volume>6</volume>:<fpage>e13557</fpage>. <pub-id pub-id-type="doi">10.14814/phy2.13557</pub-id><pub-id pub-id-type="pmid">29380539</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sills</surname><given-names>G. J.</given-names></name></person-group> (<year>2006</year>). <article-title>The mechanisms of action of gabapentin and pregabalin</article-title>. <source/>Curr. Opin. Pharmacol.
<volume>6</volume>, <fpage>108</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2005.11.003</pub-id><pub-id pub-id-type="pmid">16376147</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sintas</surname><given-names>C.</given-names></name><name><surname>Carreño</surname><given-names>O.</given-names></name><name><surname>Fernàndez-Castillo</surname><given-names>N.</given-names></name><name><surname>Corominas</surname><given-names>R.</given-names></name><name><surname>Vila-Pueyo</surname><given-names>M.</given-names></name><name><surname>Toma</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Mutation spectrum in the <italic>CACNA1A</italic> gene in 49 patients with episodic ataxia</article-title>. <source/>Sci. Rep.
<volume>7</volume>:<fpage>2514</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-02554-x</pub-id><pub-id pub-id-type="pmid">28566750</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>L. A.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Peixoto</surname><given-names>A. A.</given-names></name><name><surname>Neumann</surname><given-names>E. K.</given-names></name><name><surname>Hall</surname><given-names>L. M.</given-names></name><name><surname>Hall</surname><given-names>J. C.</given-names></name></person-group> (<year>1996</year>). <article-title>A <italic>Drosophila</italic> calcium channel α1 subunit gene maps to a genetic locus associated with behavioral and visual defects</article-title>. <source/>J. Neurosci.
<volume>16</volume>, <fpage>7868</fpage>–<lpage>7879</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-24-07868.1996</pub-id><pub-id pub-id-type="pmid">8987815</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soden</surname><given-names>S. E.</given-names></name><name><surname>Saunders</surname><given-names>C. J.</given-names></name><name><surname>Willig</surname><given-names>L. K.</given-names></name><name><surname>Farrow</surname><given-names>E. G.</given-names></name><name><surname>Smith</surname><given-names>L. D.</given-names></name><name><surname>Petrikin</surname><given-names>J. E.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders</article-title>. <source/>Sci. Transl. Med.
<volume>265</volume>:<fpage>265ra168</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3010076</pub-id><pub-id pub-id-type="pmid">25473036</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spacey</surname><given-names>S. D.</given-names></name><name><surname>Hildebrand</surname><given-names>M. E.</given-names></name><name><surname>Materek</surname><given-names>L. A.</given-names></name><name><surname>Bird</surname><given-names>T. D.</given-names></name><name><surname>Snutch</surname><given-names>T. P.</given-names></name></person-group> (<year>2004</year>). <article-title>Functional implications of a novel EA2 mutation in the P/Q-type calcium channel</article-title>. <source/>Ann. Neurol.
<volume>56</volume>, <fpage>213</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20169</pub-id><pub-id pub-id-type="pmid">15293273</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>S.</given-names></name><name><surname>Roy</surname><given-names>B.</given-names></name><name><surname>Davies</surname><given-names>G.</given-names></name><name><surname>Maksemous</surname><given-names>N.</given-names></name><name><surname>Smith</surname><given-names>R.</given-names></name><name><surname>Griffiths</surname><given-names>L. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Detection of a novel mutation in the <italic>CACNA1A</italic> gene</article-title>. <source/>Twin Res. Hum. Genet.
<volume>15</volume>, <fpage>120</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1375/twin.15.1.120</pub-id><pub-id pub-id-type="pmid">22784462</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tantsis</surname><given-names>E. M.</given-names></name><name><surname>Gill</surname><given-names>D.</given-names></name><name><surname>Griffiths</surname><given-names>L.</given-names></name><name><surname>Lawson</surname><given-names>J.</given-names></name><name><surname>Maksemous</surname><given-names>N.</given-names></name><name><surname>Ouvrier</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Eye movement disorders are an early manifestation of <italic>CACNA1A</italic> mutations in children</article-title>. <source/>Dev. Med. Child Neurol.
<volume>58</volume>, <fpage>639</fpage>–<lpage>644</lpage>. <pub-id pub-id-type="doi">10.1111/dmcn.13033</pub-id><pub-id pub-id-type="pmid">26814174</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>X.</given-names></name><name><surname>Lee</surname><given-names>A.</given-names></name><name><surname>Limapichat</surname><given-names>W.</given-names></name><name><surname>Dougherty</surname><given-names>D. A.</given-names></name><name><surname>MacKinnon</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>A gating charge transfer center in voltage sensors</article-title>. <source/>Science
<volume>328</volume>, <fpage>67</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1126/science.1185954</pub-id><pub-id pub-id-type="pmid">20360102</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarr</surname><given-names>T. B.</given-names></name><name><surname>Malick</surname><given-names>W.</given-names></name><name><surname>Liang</surname><given-names>M.</given-names></name><name><surname>Valdomir</surname><given-names>G.</given-names></name><name><surname>Frasso</surname><given-names>M.</given-names></name><name><surname>Lacomis</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndrome</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>10559</fpage>–<lpage>10567</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4629-12.2013</pub-id><pub-id pub-id-type="pmid">23785168</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomsen</surname><given-names>L. L.</given-names></name><name><surname>Kirchmann</surname><given-names>M.</given-names></name><name><surname>Bjornsson</surname><given-names>A.</given-names></name><name><surname>Stefansson</surname><given-names>H.</given-names></name><name><surname>Jensen</surname><given-names>R. M.</given-names></name><name><surname>Fasquel</surname><given-names>A. C.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>The genetic spectrum of a population-based sample of familial hemiplegic migraine</article-title>. <source/>Brain
<volume>130</volume>, <fpage>346</fpage>–<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awl334</pub-id><pub-id pub-id-type="pmid">17142831</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tonelli</surname><given-names>A.</given-names></name><name><surname>D’Angelo</surname><given-names>M. G.</given-names></name><name><surname>Salati</surname><given-names>R.</given-names></name><name><surname>Villa</surname><given-names>L.</given-names></name><name><surname>Germinasi</surname><given-names>C.</given-names></name><name><surname>Frattini</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Early onset, non-fluctuating spinocerebellar ataxia and a novel missense mutation in <italic>CACNA1A</italic> gene</article-title>. <source/>J. Neurol. Sci.
<volume>241</volume>, <fpage>13</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2005.10.007</pub-id><pub-id pub-id-type="pmid">16325861</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tottene</surname><given-names>A.</given-names></name><name><surname>Fellini</surname><given-names>T.</given-names></name><name><surname>Pagnutti</surname><given-names>S.</given-names></name><name><surname>Luvisetto</surname><given-names>S.</given-names></name><name><surname>Striessnig</surname><given-names>J.</given-names></name><name><surname>Fletcher</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Familial hemiplegic migraine mutations increase Ca<sup>2+</sup> influx through single human Ca<sub>V</sub>2.1 channels and decrease maximal Ca<sub>V</sub>2.1 current density in neurons</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>99</volume>, <fpage>13284</fpage>–<lpage>13289</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.192242399</pub-id><pub-id pub-id-type="pmid">12235360</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tottene</surname><given-names>A.</given-names></name><name><surname>Pivotto</surname><given-names>F.</given-names></name><name><surname>Fellin</surname><given-names>T.</given-names></name><name><surname>Cesetti</surname><given-names>T.</given-names></name><name><surname>van den Maagdenberg</surname><given-names>A. M.</given-names></name><name><surname>Pietrobon</surname><given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>Specific kinetic alterations of human Ca<sub>V</sub>2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma</article-title>. <source/>J. Biol. Chem.
<volume>280</volume>, <fpage>17678</fpage>–<lpage>17686</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m501110200</pub-id><pub-id pub-id-type="pmid">15743764</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travaglini</surname><given-names>L.</given-names></name><name><surname>Nardella</surname><given-names>M.</given-names></name><name><surname>Bellacchio</surname><given-names>E.</given-names></name><name><surname>D’Amico</surname><given-names>A.</given-names></name><name><surname>Capuano</surname><given-names>A.</given-names></name><name><surname>Frusciante</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Missense mutations of <italic>CACNA1A</italic> are a frequent cause of autosomal dominant nonprogressive congenital ataxia</article-title>. <source/>Eur. J. Paediatr. Neurol.
<volume>221</volume>, <fpage>450</fpage>–<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpn.2016.11.005</pub-id><pub-id pub-id-type="pmid">28007337</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>T. J.</given-names></name><name><surname>Adams</surname><given-names>M. E.</given-names></name><name><surname>Dunlap</surname><given-names>K.</given-names></name></person-group> (<year>1992</year>). <article-title>Calcium channels coupled to glutamate release identified by ω-Aga-IVA</article-title>. <source/>Science
<volume>258</volume>, <fpage>310</fpage>–<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1126/science.1357749</pub-id><pub-id pub-id-type="pmid">1357749</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyagi</surname><given-names>S.</given-names></name><name><surname>Bendrick</surname><given-names>T. R.</given-names></name><name><surname>Filipova</surname><given-names>D.</given-names></name><name><surname>Papadopoulos</surname><given-names>S.</given-names></name><name><surname>Bannister</surname><given-names>R. A.</given-names></name></person-group> (<year>2019</year>). <article-title>A mutation in Ca<sub>V</sub>2.1 linked to a severe neurodevelopmental disorder impairs channel gating</article-title>. <source/>J. Gen. Physiol.
<volume>151</volume>, <fpage>850</fpage>–<lpage>859</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201812237</pub-id><pub-id pub-id-type="pmid">31015257</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchitel</surname><given-names>O. D.</given-names></name><name><surname>Protti</surname><given-names>D. A.</given-names></name><name><surname>Sanchez</surname><given-names>V.</given-names></name><name><surname>Cherksey</surname><given-names>B. D.</given-names></name><name><surname>Sugimori</surname><given-names>M.</given-names></name><name><surname>Llinás</surname><given-names>R.</given-names></name></person-group> (<year>1992</year>). <article-title>P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>89</volume>, <fpage>3330</fpage>–<lpage>3333</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.89.8.3330</pub-id><pub-id pub-id-type="pmid">1348859</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vahedi</surname><given-names>K.</given-names></name><name><surname>Denier</surname><given-names>C.</given-names></name><name><surname>Ducros</surname><given-names>A.</given-names></name><name><surname>Bousson</surname><given-names>V.</given-names></name><name><surname>Levy</surname><given-names>C.</given-names></name><name><surname>Chabriat</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title><italic>CACNA1A</italic> gene <italic>de novo</italic> mutation causing hemiplegic migraine, coma and cerebellar atrophy</article-title>. <source/>Neurology
<volume>55</volume>, <fpage>1040</fpage>–<lpage>1042</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.55.7.1040</pub-id><pub-id pub-id-type="pmid">11061267</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Maagdenberg</surname><given-names>A. M.</given-names></name><name><surname>Kors</surname><given-names>E. E.</given-names></name><name><surname>Brunt</surname><given-names>E. R.</given-names></name><name><surname>Pascual</surname><given-names>J.</given-names></name><name><surname>Ravine</surname><given-names>D.</given-names></name><name><surname>Keeling</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Episodic ataxia type 2. Three novel truncating mutations and one novel missense mutation in the <italic>CACNA1A</italic> gene</article-title>. <source/>J. Neurol.
<volume>249</volume>, <fpage>1515</fpage>–<lpage>1519</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-002-0860-8</pub-id><pub-id pub-id-type="pmid">12420090</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Maagdenberg</surname><given-names>A. M.</given-names></name><name><surname>Pietrobon</surname><given-names>D.</given-names></name><name><surname>Pizzorusso</surname><given-names>T.</given-names></name><name><surname>Kaja</surname><given-names>S.</given-names></name><name><surname>Broos</surname><given-names>L. A. M.</given-names></name><name><surname>Cesetti</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>A <italic>CACNA1A</italic> knockin migraine mouse model with increased susceptibility to cortical spreading depression</article-title>. <source/>Neuron
<volume>41</volume>, <fpage>701</fpage>–<lpage>710</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(04)00085-6</pub-id><pub-id pub-id-type="pmid">15003170</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Maagdenberg</surname><given-names>A. M.</given-names></name><name><surname>Pizzorusso</surname><given-names>T.</given-names></name><name><surname>Kaja</surname><given-names>S.</given-names></name><name><surname>Terpolilli</surname><given-names>N.</given-names></name><name><surname>Shapovalova</surname><given-names>M.</given-names></name><name><surname>Hoebeek</surname><given-names>F. E.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>High cortical spreading depression susceptibility and migraine-associated symptoms in Ca<sub>V</sub>2.1 S218L mice</article-title>. <source/>Ann. Neurol.
<volume>67</volume>, <fpage>85</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21815</pub-id><pub-id pub-id-type="pmid">20186955</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vecchia</surname><given-names>D.</given-names></name><name><surname>Tottene</surname><given-names>A.</given-names></name><name><surname>van den Maagdenberg</surname><given-names>A. M.</given-names></name><name><surname>Pietrobon</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Abnormal cortical synaptic transmission in Ca<sub>V</sub>2.1 knockin mice with the S218L missense mutation which causes a severe familial hemiplegic migraine syndrome in humans</article-title>. <source/>Front. Cell. Neurosci.
<volume>9</volume>:<fpage>8</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00008</pub-id><pub-id pub-id-type="pmid">25741235</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volsen</surname><given-names>S. G.</given-names></name><name><surname>Day</surname><given-names>N. C.</given-names></name><name><surname>McCormack</surname><given-names>A. L.</given-names></name><name><surname>Smith</surname><given-names>W.</given-names></name><name><surname>Craig</surname><given-names>P. J.</given-names></name><name><surname>Beattie</surname><given-names>R. E.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>The expression of voltage-dependent calcium channel β subunits in human cerebellum</article-title>. <source/>Neuroscience
<volume>80</volume>, <fpage>161</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/s0306-4522(97)00115-2</pub-id><pub-id pub-id-type="pmid">9252229</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wappl</surname><given-names>E.</given-names></name><name><surname>Koschak</surname><given-names>A.</given-names></name><name><surname>Poteser</surname><given-names>M.</given-names></name><name><surname>Sinnegger</surname><given-names>M. J.</given-names></name><name><surname>Walter</surname><given-names>D.</given-names></name><name><surname>Eberhart</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Functional consequences of P/Q-type Ca<sup>2+</sup> channel Ca<sub>V</sub>2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia</article-title>. <source/>J. Biol. Chem.
<volume>277</volume>, <fpage>6960</fpage>–<lpage>6966</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110948200</pub-id><pub-id pub-id-type="pmid">11742003</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>N.</given-names></name><name><surname>Sandoval</surname><given-names>A.</given-names></name><name><surname>Felix</surname><given-names>R.</given-names></name><name><surname>van den Maagdenberg</surname><given-names>A.</given-names></name><name><surname>De Waard</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>The S218L familial hemiplegic migraine mutation promotes deinhibition of Ca<sub>V</sub>2.1 calcium channels during direct G-protein regulation</article-title>. <source/>Pflugers Arch.
<volume>457</volume>, <fpage>315</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-008-0541-2</pub-id><pub-id pub-id-type="pmid">18581134</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>N.</given-names></name><name><surname>Tournier-Lasserve</surname><given-names>E.</given-names></name><name><surname>De Waard</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Role of P/Q calcium channel in familial hemiplegic migraine</article-title>. <source/>Med. Sci.
<volume>23</volume>, <fpage>53</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1051/medsci/200723153</pub-id><pub-id pub-id-type="pmid">17212932</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>H.</given-names></name><name><surname>Linhoff</surname><given-names>M. W.</given-names></name><name><surname>Hubbard</surname><given-names>J. M.</given-names></name><name><surname>Nelson</surname><given-names>N. R.</given-names></name><name><surname>Stensland</surname><given-names>D.</given-names></name><name><surname>Dallman</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Zebrafish calls for reinterpretation for the roles of P/Q calcium channels in neuromuscular transmission</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>7384</fpage>–<lpage>7392</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5839-12.2013</pub-id><pub-id pub-id-type="pmid">23616544</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weyhrauch</surname><given-names>D. L.</given-names></name><name><surname>Ye</surname><given-names>D.</given-names></name><name><surname>Boczek</surname><given-names>N. J.</given-names></name><name><surname>Tester</surname><given-names>D. J.</given-names></name><name><surname>Gavrilova</surname><given-names>R. H.</given-names></name><name><surname>Patterson</surname><given-names>M. C.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Whole exome sequencing and heterologous cellular electrophysiology studies elucidate a novel loss-of-function mutation in the <italic>CACNA1A</italic>-encoded neuronal P/Q-type calcium channel in a child with congenital hypotonia and developmental delay</article-title>. <source/>Pediatr. Neurol.
<volume>55</volume>, <fpage>46</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2015.10.014</pub-id><pub-id pub-id-type="pmid">26739101</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>G. N.</given-names></name></person-group> (<year>2014</year>). <article-title>Exome analysis of connective tissue dysplasia: death and rebirth of clinical genetics?</article-title>
<source/>Am. J. Med. Genet. A
<volume>164A</volume>, <fpage>1209</fpage>–<lpage>1212</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36463</pub-id><pub-id pub-id-type="pmid">24664531</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>M.</given-names></name><name><surname>White</surname><given-names>B. H. V.</given-names></name><name><surname>Boehm</surname><given-names>A.</given-names></name><name><surname>Meriney</surname><given-names>C. J.</given-names></name><name><surname>Kerrigan</surname><given-names>K.</given-names></name><name><surname>Frasso</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>New Ca<sub>V</sub>2 calcium channel gating modifiers with agonist activity and therapeutic potential to treat neuromuscular disease</article-title>. <source/>Neuropharmacology
<volume>131</volume>, <fpage>176</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2017.12.022</pub-id><pub-id pub-id-type="pmid">29246857</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Qian</surname><given-names>X.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Dong</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Structure of the voltage-gated calcium channel Ca<sub>V</sub>1.1 at 3.6 Å resolution</article-title>. <source/>Nature
<volume>537</volume>, <fpage>191</fpage>–<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1038/nature19321</pub-id><pub-id pub-id-type="pmid">27580036</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Chi</surname><given-names>P.</given-names></name><name><surname>Bibb</surname><given-names>J. A.</given-names></name><name><surname>Ryan</surname><given-names>T. A.</given-names></name><name><surname>Greengard</surname><given-names>P.</given-names></name></person-group> (<year>2002</year>). <article-title>Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons</article-title>. <source/>J. Physiol.
<volume>540</volume>, <fpage>761</fpage>–<lpage>770</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2001.013376</pub-id><pub-id pub-id-type="pmid">11986366</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Ellinor</surname><given-names>P. T.</given-names></name><name><surname>Sather</surname><given-names>W. A.</given-names></name><name><surname>Zhang</surname><given-names>J. F.</given-names></name><name><surname>Tsien</surname><given-names>R. W.</given-names></name></person-group> (<year>1993</year>). <article-title>Molecular determinants of Ca<sup>2+</sup> selectivity and ion permeation in L-type Ca<sup>2+</sup> channels</article-title>. <source/>Nature
<volume>366</volume>, <fpage>158</fpage>–<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1038/366158a0</pub-id><pub-id pub-id-type="pmid">8232554</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Muzny</surname><given-names>D. M.</given-names></name><name><surname>Xia</surname><given-names>F.</given-names></name><name><surname>Niu</surname><given-names>Z.</given-names></name><name><surname>Person</surname><given-names>R.</given-names></name><name><surname>Ding</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Molecular findings among patients referred for clinical whole-exome sequencing</article-title>. <source/>JAMA
<volume>312</volume>, <fpage>1870</fpage>–<lpage>1879</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2014.14601</pub-id><pub-id pub-id-type="pmid">25326635</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>D.</given-names></name><name><surname>Tester</surname><given-names>D. J.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Papagiannis</surname><given-names>J.</given-names></name><name><surname>Ackerman</surname><given-names>M. J.</given-names></name></person-group> (<year>2019</year>). <article-title>A pore-localizing CACNA1C-E1115K missense mutation, identified in a patient with idiopathicQT prolongation, bradycardia and autism spectrum disorder, converts the L-type calcium channel into a hybrid nonselective monovalent cation channel</article-title>. <source/>Heart Rhythm.
<volume>16</volume>, <fpage>270</fpage>–<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2018.08.030</pub-id><pub-id pub-id-type="pmid">30172029</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>Q.</given-names></name><name><surname>Jen</surname><given-names>J. C.</given-names></name><name><surname>Nelson</surname><given-names>S. F.</given-names></name><name><surname>Baloh</surname><given-names>R. W.</given-names></name></person-group> (<year>1997</year>). <article-title>Progressive ataxia due to a missense mutation in a calcium-channel gene</article-title>. <source/>Am. J. Hum. Genet.
<volume>61</volume>, <fpage>1078</fpage>–<lpage>1087</lpage>. <pub-id pub-id-type="doi">10.1086/301613</pub-id><pub-id pub-id-type="pmid">9345107</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zafeiriou</surname><given-names>D. I.</given-names></name><name><surname>Lehmann-Horn</surname><given-names>F.</given-names></name><name><surname>Vargiami</surname><given-names>E.</given-names></name><name><surname>Teflioudi</surname><given-names>E.</given-names></name><name><surname>Ververi</surname><given-names>A.</given-names></name><name><surname>Jurkat-Rott</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Episodic ataxia type 2 showing ictal hyperhidrosis with hypothermia and interictal chronic diarrhea due to a novel <italic>CACNA1A</italic> mutation</article-title>. <source/>Eur. J. Paediatr. Neurol.
<volume>13</volume>, <fpage>191</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpn.2008.02.011</pub-id><pub-id pub-id-type="pmid">18602318</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>G.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>Molecular basis for ligand modulation of a mammalian voltage-gated Ca<sup>2+</sup> channel</article-title>. <source/>Cell
<volume>177</volume>, <fpage>1495</fpage>–<lpage>1506</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2019.04.043</pub-id><pub-id pub-id-type="pmid">31150622</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>